,Log2 fold change,std error (log2),Lower confidence limit (log2),Upper confidence limit (log2),Linear fold change,Lower confidence limit (linear),Upper confidence limit (linear),P-value,BY.p.value,method,Gene.sets,probe.ID
PLXDC2-mRNA,1.21,0.198,0.824,1.6,2.32,1.77,3.03,5.52E-06,0.0136,lm.nb,Microglial Markers,NM_032812.7:685
PLAA-mRNA,-0.552,0.0903,-0.729,-0.375,0.682,0.603,0.771,5.63E-06,0.0136,loglinear,"Neurogenesis, Proteotoxic Stress",NM_001031689.2:574
ERBB3-mRNA,1.54,0.293,0.97,2.12,2.92,1.96,4.34,3.66E-05,0.0431,lm.nb,"MAPK & PI3K, Neurogenesis",NM_001005915.1:261
EGR1-mRNA,-1.77,0.338,-2.43,-1.11,0.293,0.185,0.464,3.98E-05,0.0431,lm.nb,"Cytokines, Interferon Signaling, Microglia Neurodegenerative Phenotype (MGnD), Microglial Markers",NM_001964.2:838
P2RX7-mRNA,1.34,0.259,0.835,1.85,2.53,1.78,3.6,4.44E-05,0.0431,lm.nb,"Calcium Signaling, Inflammasome, Neuroactive Ligands and Receptors",NM_002562.5:780
HSD17B4-mRNA,0.427,0.0868,0.256,0.597,1.34,1.19,1.51,8.36E-05,0.0675,lm.nb,Lipid Metabolism,NM_000414.3:2235
IP6K2-mRNA,0.509,0.109,0.296,0.722,1.42,1.23,1.65,0.000142,0.0941,lm.nb,Interferon Signaling,NM_001005910.2:277
PLXNB3-mRNA,1.64,0.353,0.948,2.33,3.12,1.93,5.03,0.000155,0.0941,lm.nb,Neurogenesis,NM_001163257.1:3663
ACLY-mRNA,-0.646,0.145,-0.931,-0.362,0.639,0.525,0.778,0.000243,0.131,lm.nb,Lipid Metabolism,NM_001096.2:3195
OLIG2-mRNA,0.862,0.201,0.469,1.25,1.82,1.38,2.39,0.000352,0.17,lm.nb,"Myelogenesis, Oligodendrocyte DifferentiationMaturation",NM_005806.3:400
UGT8-mRNA,1.31,0.308,0.708,1.92,2.48,1.63,3.77,0.000385,0.17,lm.nb,"Myelogenesis, Oligodendrocyte Markers",NM_001128174.1:1135
UBE4B-mRNA,0.33,0.0786,0.176,0.484,1.26,1.13,1.4,0.000444,0.173,lm.nb,"Neurogenesis, Proteotoxic Stress",NM_006048.3:1560
SOX10-mRNA,1.18,0.285,0.625,1.74,2.27,1.54,3.35,0.000494,0.173,lm.nb,"Myelogenesis, Neurogenesis, Oligodendrocyte DifferentiationMaturation, Oligodendrocyte Markers",NM_006941.3:1057
UBE2N-mRNA,-0.597,0.144,-0.88,-0.315,0.661,0.543,0.804,5.00E-04,0.173,lm.nb,Antigen Processing and Presentation,NM_003348.4:357
PSMA5-mRNA,-0.71,0.174,-1.05,-0.369,0.611,0.483,0.774,0.000585,0.189,lm.nb,Antigen Processing and Presentation,NM_002790.2:235
PKD2-mRNA,0.502,0.125,0.256,0.747,1.42,1.19,1.68,0.000692,0.19,lm.nb,NO Metabolism and Signaling,NM_000297.2:2565
OLIG1-mRNA,1.23,0.307,0.627,1.83,2.34,1.54,3.55,0.000697,0.19,lm.nb,Oligodendrocyte DifferentiationMaturation,NM_138983.3:102
TXN-mRNA,-0.627,0.157,-0.934,-0.32,0.648,0.523,0.801,0.000707,0.19,lm.nb,"Inflammasome, Oxidative & Nitrosative Stress, Primed Microglia",NM_003329.2:55
BIN1-mRNA,0.571,0.144,0.289,0.854,1.49,1.22,1.81,0.000765,0.195,lm.nb,"Cytoskeletal Dynamics, Microglia Neurodegenerative Phenotype (MGnD), Phagocytosis, Primed Microglia",NM_004305.4:379
EMP1-mRNA,-2.71,0.687,-4.05,-1.36,0.153,0.0602,0.389,0.000807,0.195,lm.nb,A2 Astrocyte,NM_001423.2:364
LAMP2-mRNA,0.843,0.215,0.421,1.27,1.79,1.34,2.4,0.000853,0.197,lm.nb,Autophagy,NM_002294.2:380
GRN-mRNA,0.576,0.148,0.285,0.866,1.49,1.22,1.82,0.000926,0.202,lm.nb,"Astrocyte DifferentiationFunction, Microglia Neurodegenerative Phenotype (MGnD), Neurogenesis, Primed Microglia",NM_002087.2:546
FA2H-mRNA,1.42,0.368,0.696,2.14,2.67,1.62,4.41,0.000999,0.202,lm.nb,"Myelogenesis, Oligodendrocyte DifferentiationMaturation",NM_024306.2:360
STAT1-mRNA,-0.811,0.212,-1.23,-0.395,0.57,0.428,0.76,0.00106,0.202,lm.nb,"JAK-STAT, Primed Microglia",NM_139266.1:455
SLC38A2-mRNA,0.905,0.237,0.44,1.37,1.87,1.36,2.58,0.00107,0.202,lm.nb,"GABAergic Synapse, Glutamatergic Synapse, Oligodendrocyte Markers",NM_018976.4:1170
CSF1R-mRNA,1.15,0.3,0.557,1.74,2.21,1.47,3.33,0.00108,0.202,lm.nb,"Cytokines, Homeostatic Microglia, Microglia Neurodegenerative Phenotype (MGnD), Microglial Markers, Primed Microglia",NM_005211.3:455
VDAC1-mRNA,-0.621,0.166,-0.946,-0.295,0.65,0.519,0.815,0.00129,0.231,lm.nb,"Autophagy, Calcium Signaling",NM_003374.3:755
KPNA1-mRNA,-0.361,0.1,-0.557,-0.164,0.779,0.68,0.892,0.00179,0.306,lm.nb,"Apoptosis, Interferon Signaling",NM_002264.2:1420
ATP5PB-mRNA,-0.506,0.141,-0.782,-0.229,0.704,0.581,0.853,0.00185,0.306,lm.nb,Glucose Metabolism,NM_001688.4:645
PRKAG1-mRNA,-0.818,0.23,-1.27,-0.368,0.567,0.415,0.775,0.00196,0.306,lm.nb,Glucose Metabolism,NM_002733.3:825
CHI3L1-mRNA,-2.78,0.781,-4.31,-1.25,0.146,0.0505,0.422,0.00198,0.306,lm.nb,Astrocyte Markers,NM_001276.2:475
BHLHE40-mRNA,-0.587,0.166,-0.912,-0.262,0.666,0.531,0.834,0.00206,0.306,lm.nb,"Circadian Signaling, Microglia Neurodegenerative Phenotype (MGnD)",NM_003670.2:716
GSK3B-mRNA,-0.39,0.11,-0.606,-0.174,0.763,0.657,0.887,0.00209,0.306,lm.nb,"Cell Cycle, Cytoskeletal Dynamics, Neurogenesis, Neurotrophin Signaling, Wnt Signaling",NM_002093.2:925
ELOC-mRNA,-0.71,0.205,-1.11,-0.309,0.611,0.463,0.807,0.00242,0.345,lm.nb,"Antigen Processing and Presentation, Hypoxia",NM_001204857.1:124
ABI2-mRNA,-0.354,0.103,-0.556,-0.152,0.782,0.68,0.9,0.00261,0.352,lm.nb,"Angiogenesis, Neurogenesis",NM_005759.5:1160
TLR4-mRNA,0.971,0.283,0.417,1.53,1.96,1.34,2.88,0.00262,0.352,lm.nb,"Apoptosis, Astrocyte DifferentiationFunction, NF-kappaB Signaling, NO Metabolism and Signaling",NM_138554.2:2570
ANAPC1-mRNA,-0.423,0.125,-0.668,-0.178,0.746,0.63,0.884,0.00296,0.382,lm.nb,Cell Cycle,NM_022662.2:1990
TREM2-mRNA,1.22,0.361,0.511,1.93,2.33,1.43,3.8,0.00301,0.382,lm.nb,"Astrocyte DifferentiationFunction, Microglia Neurodegenerative Phenotype (MGnD), Stage 2 DAM",NM_018965.3:355
ARPC2-mRNA,-0.309,0.0918,-0.489,-0.129,0.807,0.713,0.914,0.00308,0.382,lm.nb,Phagocytosis,NM_152862.1:755
ERMN-mRNA,1.08,0.325,0.447,1.72,2.12,1.36,3.3,0.0033,0.391,lm.nb,"Cytoskeletal Dynamics, Oligodendrocyte Markers",NM_001304344.1:440
QDPR-mRNA,0.867,0.26,0.357,1.38,1.82,1.28,2.6,0.00331,0.391,lm.nb,Oligodendrocyte Markers,NM_001306140.1:305
EIF2B5-mRNA,0.267,0.0813,0.107,0.426,1.2,1.08,1.34,0.00373,0.422,lm.nb,"Astrocyte DifferentiationFunction, Myelogenesis, Oligodendrocyte DifferentiationMaturation",NM_003907.2:1098
MYRF-mRNA,1.31,0.4,0.523,2.09,2.47,1.44,4.26,0.00387,0.422,lm.nb,"Myelogenesis, Oligodendrocyte DifferentiationMaturation",NM_013279.4:1130
MAFB-mRNA,0.61,0.187,0.243,0.977,1.53,1.18,1.97,0.00392,0.422,lm.nb,"Microglia Neurodegenerative Phenotype (MGnD), Microglial Markers",NM_005461.4:1231
ZPR1-mRNA,-0.544,0.167,-0.87,-0.217,0.686,0.547,0.861,0.00392,0.422,lm.nb,"Cytoskeletal Dynamics, Neurogenesis",NM_003904.3:1215
IGFBP5-mRNA,1.03,0.316,0.405,1.65,2.04,1.32,3.13,0.00409,0.426,lm.nb,Insulin Signaling,NM_000599.3:1188
STAT2-mRNA,0.444,0.137,0.175,0.713,1.36,1.13,1.64,0.00413,0.426,lm.nb,JAK-STAT,NM_005419.3:1390
FABP5-mRNA,-1.67,0.526,-2.7,-0.635,0.315,0.154,0.644,0.00485,0.487,lm.nb,Microglia Neurodegenerative Phenotype (MGnD),NM_001444.1:100
CSNK2A1/3-mRNA,-0.406,0.128,-0.658,-0.154,0.755,0.634,0.899,0.00493,0.487,lm.nb,"NF-kappaB Signaling, Wnt Signaling",NM_001895.4:689
ACADSB-mRNA,-0.797,0.257,-1.3,-0.292,0.576,0.406,0.817,0.00571,0.545,lm.nb,Lipid Metabolism,NM_001609.3:770
CAMK4-mRNA,-0.756,0.244,-1.23,-0.277,0.592,0.425,0.825,0.00573,0.545,lm.nb,Calcium Signaling,NM_001744.3:1220
FOS-mRNA,-1.66,0.543,-2.72,-0.592,0.317,0.152,0.663,0.00631,0.588,lm.nb,"MAPK & PI3K, T-cell signaling",NM_005252.3:554
TGFB1-mRNA,0.779,0.261,0.267,1.29,1.72,1.2,2.45,0.00735,0.671,lm.nb,"Microglia Neurodegenerative Phenotype (MGnD), TGF-Beta Signaling",NM_000660.4:1438
EGFR-mRNA,0.633,0.214,0.214,1.05,1.55,1.16,2.07,0.00769,0.684,lm.nb,"Astrocyte DifferentiationFunction, MAPK & PI3K, Neurogenesis",NM_201282.1:1354
BHLHE41-mRNA,0.533,0.181,0.179,0.888,1.45,1.13,1.85,0.00796,0.684,lm.nb,"Circadian Signaling, Microglial Markers",NM_030762.2:655
NRCAM-mRNA,-0.352,0.12,-0.586,-0.117,0.784,0.666,0.922,0.0081,0.684,lm.nb,"Astrocyte Markers, Cell Migration, Cytoskeletal Dynamics, Neurogenesis",NM_005010.4:875
CTSS-mRNA,0.879,0.3,0.291,1.47,1.84,1.22,2.77,0.00833,0.684,lm.nb,"Apoptosis, Homeostatic Microglia",NM_004079.3:685
CXCL8-mRNA,-2.26,0.773,-3.78,-0.745,0.209,0.073,0.597,0.0084,0.684,lm.nb,"Chemokines, NF-kappaB Signaling",NM_000584.3:221
NCAM1-mRNA,0.333,0.114,0.109,0.557,1.26,1.08,1.47,0.00856,0.684,lm.nb,"Cell Migration, Neurogenesis, Neuronal Markers",NM_000615.5:1620
ATP6V1G1-mRNA,-0.432,0.148,-0.723,-0.142,0.741,0.606,0.907,0.00857,0.684,lm.nb,"Ion Transport, Phagocytosis",NM_004888.4:300
ADCYAP1R1-mRNA,0.558,0.192,0.182,0.934,1.47,1.13,1.91,0.00865,0.684,lm.nb,"Astrocyte Markers, Neuroactive Ligands and Receptors, Neurotrophin Signaling",NM_001118.3:935
PPP2CA-mRNA,-0.505,0.174,-0.845,-0.164,0.705,0.557,0.892,0.00875,0.684,lm.nb,TGF-Beta Signaling,NM_002715.2:1075
RTN4-mRNA,-0.585,0.202,-0.98,-0.189,0.667,0.507,0.877,0.00897,0.69,lm.nb,"Blood Brain Barrier, Neurogenesis",NM_007008.2:275
FCGRT-mRNA,0.789,0.275,0.25,1.33,1.73,1.19,2.51,0.00948,0.718,lm.nb,Astrocyte Markers,XM_011526628.1:205
PRKAR1A-mRNA,-0.441,0.155,-0.744,-0.137,0.737,0.597,0.909,0.00999,0.745,lm.nb,Insulin Signaling,NM_212472.1:367
B4GALT5-mRNA,-0.479,0.169,-0.81,-0.148,0.718,0.57,0.903,0.0102,0.752,lm.nb,"Myelogenesis, Oligodendrocyte DifferentiationMaturation",NM_004776.3:930
KCNQ3-mRNA,-0.83,0.294,-1.41,-0.253,0.562,0.377,0.839,0.0105,0.762,lm.nb,"Cholinergic Synapse, Ion Transport",NM_004519.2:665
JUN-mRNA,-0.763,0.271,-1.29,-0.232,0.589,0.408,0.852,0.0107,0.762,lm.nb,"MAPK & PI3K, Microglia Neurodegenerative Phenotype (MGnD), Microglial Markers, Neurogenesis, T-cell signaling, Wnt Signaling",NM_002228.3:1952
SPI1-mRNA,0.657,0.236,0.195,1.12,1.58,1.14,2.17,0.0114,0.765,lm.nb,Microglia Neurodegenerative Phenotype (MGnD),NM_003120.1:730
ADAMTS1-mRNA,-0.971,0.349,-1.65,-0.288,0.51,0.318,0.819,0.0114,0.765,lm.nb,Microglial Markers,NM_006988.3:2840
SLC46A1-mRNA,0.533,0.192,0.157,0.909,1.45,1.12,1.88,0.0115,0.765,lm.nb,Ion Transport,NM_001242366.1:754
C3-mRNA,1.18,0.424,0.348,2.01,2.26,1.27,4.03,0.0115,0.765,lm.nb,"Complement System, Neuroactive Ligands and Receptors, Primed Microglia",NM_000064.2:4396
DLAT-mRNA,-0.487,0.175,-0.83,-0.144,0.714,0.563,0.905,0.0115,0.765,lm.nb,Glucose Metabolism,NM_001931.5:1825
TSC1-mRNA,0.267,0.0969,0.0768,0.457,1.2,1.05,1.37,0.0123,0.794,lm.nb,"Autophagy, Cytoskeletal Dynamics, Insulin Signaling, Neurogenesis",NM_001162427.1:2072
RASGRF1-mRNA,-0.633,0.23,-1.09,-0.182,0.645,0.471,0.882,0.0124,0.794,lm.nb,"MAPK & PI3K, Neurogenesis",NM_001145648.1:3444
TRIM68-mRNA,0.236,0.086,0.0676,0.405,1.18,1.05,1.32,0.0125,0.794,loglinear,Interferon Signaling,NM_001304496.2:560
PAK1-mRNA,-0.805,0.297,-1.39,-0.223,0.572,0.382,0.857,0.0134,0.845,lm.nb,"Cell Migration, Cytoskeletal Dynamics, MAPK & PI3K, Neurogenesis, Phagocytosis, T-cell signaling",NM_002576.3:975
GBP2-mRNA,-1.55,0.576,-2.67,-0.418,0.342,0.157,0.748,0.0142,0.863,lm.nb,"A1 Astrocyte, Interferon Signaling, Primed Microglia",NM_004120.3:780
PTPN1-mRNA,-0.424,0.159,-0.735,-0.114,0.745,0.601,0.924,0.0145,0.863,lm.nb,"Insulin Signaling, Interferon Signaling",NM_002827.3:664
MEAF6-mRNA,-0.397,0.149,-0.689,-0.106,0.759,0.62,0.929,0.0147,0.863,lm.nb,"Myelogenesis, Neurogenesis",NM_001270875.2:180
GPRASP1-mRNA,-0.726,0.272,-1.26,-0.193,0.605,0.418,0.875,0.0148,0.863,lm.nb,Primed Microglia,NM_001099410.1:1375
LGALS3-mRNA,-0.991,0.372,-1.72,-0.262,0.503,0.303,0.834,0.0149,0.863,lm.nb,"Microglia Neurodegenerative Phenotype (MGnD), Primed Microglia",NM_001177388.1:495
CLTC-mRNA,-0.391,0.147,-0.68,-0.103,0.762,0.624,0.931,0.015,0.863,lm.nb,"Gap Junctions, Wnt Signaling",NM_004859.2:290
PDGFRA-mRNA,0.494,0.186,0.129,0.86,1.41,1.09,1.81,0.0152,0.863,lm.nb,MAPK & PI3K,NM_006206.3:1925
IL18-mRNA,1.21,0.455,0.314,2.1,2.31,1.24,4.28,0.0154,0.863,lm.nb,"Astrocyte Markers, Cytokines",NM_001562.3:364
HK1-mRNA,-0.32,0.121,-0.556,-0.0832,0.801,0.68,0.944,0.0154,0.863,lm.nb,Glucose Metabolism,NM_033496.2:1900
CPNE2-mRNA,0.544,0.206,0.141,0.948,1.46,1.1,1.93,0.0156,0.863,lm.nb,Astrocyte Markers,NM_152727.5:1126
CNP-mRNA,0.675,0.256,0.174,1.18,1.6,1.13,2.26,0.0157,0.863,lm.nb,"Myelogenesis, Oligodendrocyte DifferentiationMaturation",NM_033133.5:826
YWHAE-mRNA,-0.397,0.152,-0.694,-0.0997,0.76,0.618,0.933,0.0165,0.896,lm.nb,"Cell Cycle, Neurogenesis, Neurotrophin Signaling",NM_006761.4:770
ACSL3-mRNA,-0.435,0.167,-0.762,-0.108,0.74,0.59,0.928,0.0169,0.904,lm.nb,Lipid Metabolism,NM_203372.1:1219
GSN-mRNA,0.738,0.283,0.182,1.29,1.67,1.13,2.45,0.017,0.904,lm.nb,"Cytoskeletal Dynamics, Oligodendrocyte DifferentiationMaturation, Phagocytosis",NM_000177.4:1075
KCTD12-mRNA,0.679,0.262,0.166,1.19,1.6,1.12,2.29,0.0173,0.91,lm.nb,GABAergic Synapse,NM_138444.2:450
KRAS-mRNA,-0.489,0.189,-0.86,-0.118,0.712,0.551,0.921,0.0177,0.91,lm.nb,"Astrocyte DifferentiationFunction, MAPK & PI3K",NM_033360.2:267
LGMN-mRNA,-0.639,0.248,-1.12,-0.154,0.642,0.459,0.899,0.0178,0.91,lm.nb,"Antigen Processing and Presentation, Microglial Markers",NM_001008530.2:522
PSMD14-mRNA,-0.308,0.12,-0.543,-0.0739,0.808,0.686,0.95,0.018,0.91,lm.nb,Antigen Processing and Presentation,NM_005805.4:700
PTPRM-mRNA,-0.418,0.162,-0.737,-0.1,0.748,0.6,0.933,0.018,0.91,lm.nb,"Cell Migration, Neurogenesis",NM_002845.3:1680
DNAJB9-mRNA,-0.589,0.23,-1.04,-0.139,0.665,0.487,0.908,0.0185,0.917,lm.nb,Proteotoxic Stress,NM_012328.1:380
PSMC6-mRNA,-0.394,0.154,-0.696,-0.0928,0.761,0.617,0.938,0.0186,0.917,lm.nb,Antigen Processing and Presentation,NM_002806.3:412
ATP6V0D1-mRNA,-0.497,0.195,-0.879,-0.116,0.708,0.544,0.923,0.0188,0.917,lm.nb,"Cytoskeletal Dynamics, Ion Transport, Phagocytosis",NM_004691.4:970
PLP1-mRNA,0.8,0.313,0.186,1.41,1.74,1.14,2.67,0.0189,0.917,lm.nb,"Astrocyte DifferentiationFunction, Myelogenesis, Oligodendrocyte DifferentiationMaturation, Oligodendrocyte Markers",NM_000533.3:758
PLEKHB1-mRNA,0.828,0.325,0.19,1.46,1.77,1.14,2.76,0.0192,0.923,lm.nb,,NM_021200.3:575
ACSL4-mRNA,-0.587,0.232,-1.04,-0.132,0.666,0.486,0.912,0.0199,0.946,lm.nb,"Lipid Metabolism, Neurogenesis",NM_004458.2:385
ARPC5L-mRNA,-0.472,0.187,-0.839,-0.104,0.721,0.559,0.93,0.0206,0.967,lm.nb,Phagocytosis,NM_030978.3:1490
OPA1-mRNA,-0.545,0.219,-0.974,-0.116,0.685,0.509,0.923,0.0217,0.989,lm.nb,"Apoptosis, Neurogenesis",NM_130837.1:1355
TM4SF1-mRNA,-1.07,0.429,-1.91,-0.226,0.477,0.266,0.855,0.0218,0.989,lm.nb,A2 Astrocyte,NM_014220.2:263
GPM6A-mRNA,-0.531,0.213,-0.949,-0.112,0.692,0.518,0.925,0.0218,0.989,lm.nb,"Astrocyte Markers, Cytoskeletal Dynamics, Neurogenesis",NM_005277.3:790
SOX9-mRNA,0.644,0.259,0.136,1.15,1.56,1.1,2.22,0.0219,0.989,lm.nb,"Astrocyte Markers, Neurogenesis, Oligodendrocyte DifferentiationMaturation",NM_000346.3:868
SCOC-mRNA,-0.686,0.278,-1.23,-0.142,0.622,0.426,0.906,0.0226,0.989,lm.nb,"Microglial Markers, Primed Microglia",NM_032547.3:285
ATP5MC3-mRNA,-0.439,0.178,-0.787,-0.0907,0.738,0.579,0.939,0.0226,0.989,lm.nb,Glucose Metabolism,NM_001002258.4:340
CDC42-mRNA,-0.31,0.126,-0.557,-0.064,0.806,0.68,0.957,0.0227,0.989,lm.nb,"Cell Migration, Neurogenesis",NM_001039802.1:390
RLIM-mRNA,-0.519,0.211,-0.933,-0.106,0.698,0.524,0.929,0.0229,0.989,lm.nb,Antigen Processing and Presentation,NM_183353.2:975
SALL1-mRNA,0.619,0.252,0.126,1.11,1.54,1.09,2.16,0.0232,0.989,lm.nb,"Microglia Neurodegenerative Phenotype (MGnD), Neurogenesis",NM_002968.2:1120
C1QBP-mRNA,-0.413,0.168,-0.742,-0.0837,0.751,0.598,0.944,0.0232,0.989,lm.nb,"A1 Astrocyte, Apoptosis",NM_001212.3:745
EPB41L2-mRNA,0.229,0.0932,0.046,0.412,1.17,1.03,1.33,0.0235,0.989,lm.nb,Cytoskeletal Dynamics,NM_001199389.1:1880
ERLEC1-mRNA,-0.675,0.275,-1.21,-0.136,0.626,0.431,0.91,0.0235,0.989,lm.nb,Proteotoxic Stress,NM_001127397.2:810
ATRN-mRNA,-0.309,0.126,-0.557,-0.0614,0.807,0.68,0.958,0.0238,0.989,lm.nb,Myelogenesis,NM_001207047.1:1544
SERINC3-mRNA,-0.27,0.111,-0.487,-0.0536,0.829,0.714,0.964,0.0239,0.989,lm.nb,"Microglia Neurodegenerative Phenotype (MGnD), Primed Microglia",NM_006811.2:185
PSMD10-mRNA,-0.328,0.135,-0.591,-0.0638,0.797,0.664,0.957,0.0244,0.999,lm.nb,Antigen Processing and Presentation,NM_002814.2:275
GPR34-mRNA,1.16,0.475,0.224,2.09,2.23,1.17,4.25,0.0245,0.999,lm.nb,"Microglia Neurodegenerative Phenotype (MGnD), Microglial Markers, Primed Microglia",NM_005300.2:170
DNAJC5-mRNA,-0.431,0.178,-0.78,-0.0815,0.742,0.582,0.945,0.0253,1,lm.nb,"GABAergic Synapse, Proteotoxic Stress",NM_025219.3:230
TSPAN7-mRNA,-0.619,0.257,-1.12,-0.115,0.651,0.459,0.923,0.0259,1,lm.nb,Astrocyte Markers,NM_004615.3:725
PDHB-mRNA,-0.323,0.134,-0.586,-0.0598,0.8,0.666,0.959,0.026,1,lm.nb,Glucose Metabolism,NM_000925.3:555
SERPINA3-mRNA,-2.16,0.904,-3.93,-0.388,0.224,0.0654,0.764,0.0268,1,lm.nb,Astrocyte Markers,NM_001085.4:1220
YWHAZ-mRNA,-0.554,0.232,-1.01,-0.0983,0.681,0.497,0.934,0.0272,1,lm.nb,"Cell Cycle, Neurogenesis, Wnt Signaling",NM_001135699.1:515
MAPK9-mRNA,-0.447,0.188,-0.816,-0.0775,0.734,0.568,0.948,0.0279,1,lm.nb,MAPK & PI3K,NM_001135044.1:268
CDC27-mRNA,-0.343,0.145,-0.627,-0.0586,0.789,0.648,0.96,0.0283,1,lm.nb,Cell Cycle,NM_001256.3:2550
UBE2D2-mRNA,-0.178,0.0755,-0.326,-0.03,0.884,0.798,0.979,0.0287,1,loglinear,"Antigen Processing and Presentation, Proteotoxic Stress",NM_181838.1:1088
MOG-mRNA,0.955,0.407,0.158,1.75,1.94,1.12,3.37,0.0292,1,lm.nb,Oligodendrocyte Markers,NM_001008228.2:662
MYORG-mRNA,0.504,0.215,0.0832,0.925,1.42,1.06,1.9,0.0293,1,lm.nb,,NM_020702.5:1180
AMIGO1-mRNA,-0.478,0.204,-0.878,-0.0787,0.718,0.544,0.947,0.0294,1,lm.nb,"Myelogenesis, Neurogenesis, Primed Microglia",NM_020703.2:1455
POR-mRNA,-0.405,0.174,-0.746,-0.0641,0.755,0.596,0.957,0.0305,1,lm.nb,NO Metabolism and Signaling,NM_000941.2:114
ATP6V1D-mRNA,-0.421,0.181,-0.775,-0.0666,0.747,0.584,0.955,0.0305,1,lm.nb,"Ion Transport, Phagocytosis",NM_015994.2:390
NDUFB5-mRNA,-0.565,0.243,-1.04,-0.0888,0.676,0.486,0.94,0.0307,1,lm.nb,Cannabinoid Signaling,NM_002492.3:502
GAS7-mRNA,-0.406,0.176,-0.751,-0.0606,0.755,0.594,0.959,0.0321,1,lm.nb,"Neurogenesis, Primed Microglia",NM_201433.2:690
C1QA-mRNA,0.865,0.376,0.129,1.6,1.82,1.09,3.03,0.0322,1,lm.nb,"Astrocyte DifferentiationFunction, Complement System, Homeostatic Microglia, Microglial Markers",NM_015991.2:718
DLD-mRNA,-0.421,0.183,-0.779,-0.0626,0.747,0.583,0.958,0.0322,1,lm.nb,Glucose Metabolism,NM_000108.3:766
ACAT2-mRNA,-0.571,0.25,-1.06,-0.0811,0.673,0.48,0.945,0.0334,1,lm.nb,Lipid Metabolism,NM_005891.2:910
LAMTOR3-mRNA,-0.26,0.115,-0.485,-0.035,0.835,0.715,0.976,0.0348,1,lm.nb,Autophagy,NM_001243736.1:486
NWD1-mRNA,0.881,0.393,0.111,1.65,1.84,1.08,3.14,0.0365,1,lm.nb,,NM_001007525.3:3302
PRKCI-mRNA,-0.26,0.116,-0.487,-0.0326,0.835,0.713,0.978,0.0365,1,lm.nb,"Insulin Signaling, Neurogenesis",NM_002740.5:408
STXBP1-mRNA,-0.527,0.236,-0.988,-0.0647,0.694,0.504,0.956,0.037,1,lm.nb,Neurogenesis,NM_001032221.3:1620
GNB1-mRNA,-0.166,0.0749,-0.313,-0.0193,0.891,0.805,0.987,0.0383,1,loglinear,"Cannabinoid Signaling, Cholinergic Synapse, Dopaminergic Synapse, GABAergic Synapse, Glutamatergic Synapse, Serotonergic Synapse",NM_001282539.1:670
GFAP-mRNA,1.08,0.49,0.123,2.04,2.12,1.09,4.13,0.0389,1,lm.nb,"Astrocyte DifferentiationFunction, Astrocyte Markers, Cytoskeletal Dynamics, JAK-STAT",NM_002055.4:589
TSPO-mRNA,0.538,0.245,0.0585,1.02,1.45,1.04,2.03,0.0398,1,lm.nb,"Neuroactive Ligands and Receptors, Neurogenesis, NO Metabolism and Signaling",NM_000714.6:482
APLP2-mRNA,-0.233,0.106,-0.441,-0.0253,0.851,0.737,0.983,0.0398,1,lm.nb,Primed Microglia,NM_001642.2:1380
AKT3-mRNA,-0.285,0.13,-0.54,-0.0304,0.821,0.688,0.979,0.0402,1,lm.nb,MAPK & PI3K,NM_005465.4:287
CD74-mRNA,0.785,0.358,0.0834,1.49,1.72,1.06,2.8,0.0403,1,lm.nb,"Antigen Processing and Presentation, Microglial Markers, Primed Microglia",NM_001025158.2:189
PPT1-mRNA,-0.2,0.0917,-0.38,-0.0203,0.87,0.768,0.986,0.0412,1,lm.nb,Lipid Metabolism,NM_000310.3:826
CCL2-mRNA,-1.36,0.625,-2.59,-0.136,0.389,0.167,0.91,0.0416,1,lm.nb,"Chemokines, Microglial Markers",NM_002982.3:123
TYROBP-mRNA,0.892,0.412,0.0831,1.7,1.86,1.06,3.25,0.043,1,lm.nb,"Microglia Neurodegenerative Phenotype (MGnD), Stage 1 DAM",NM_003332.3:361
TICAM1-mRNA,0.481,0.224,0.0414,0.921,1.4,1.03,1.89,0.0444,1,lm.nb,"Apoptosis, NF-kappaB Signaling, NO Metabolism and Signaling",NM_014261.1:518
ATP6V1A-mRNA,-0.564,0.263,-1.08,-0.0483,0.676,0.473,0.967,0.0446,1,lm.nb,"Ion Transport, Phagocytosis, Primed Microglia",NM_001690.2:1320
TBK1-mRNA,0.191,0.0896,0.0156,0.367,1.14,1.01,1.29,0.0454,1,lm.nb,"Autophagy, Cytokines, NF-kappaB Signaling",NM_013254.2:1610
DLGAP1-mRNA,-0.562,0.265,-1.08,-0.0435,0.677,0.473,0.97,0.0463,1,lm.nb,Glutamatergic Synapse,NM_001003809.2:1222
SPP1-mRNA,0.828,0.392,0.0591,1.6,1.77,1.04,3.02,0.0476,1,lm.nb,"Microglia Neurodegenerative Phenotype (MGnD), Neurogenesis, Primed Microglia",NM_000582.2:760
CABLES1-mRNA,0.594,0.282,0.0421,1.15,1.51,1.03,2.21,0.0477,1,lm.nb,Cell Cycle,NM_001256438.1:955
MAG-mRNA,0.928,0.443,0.06,1.8,1.9,1.04,3.47,0.0491,1,lm.nb,"Myelogenesis, Oligodendrocyte DifferentiationMaturation",NM_001199216.1:1780
MERTK-mRNA,0.483,0.231,0.031,0.936,1.4,1.02,1.91,0.0492,1,lm.nb,"Microglia Neurodegenerative Phenotype (MGnD), Primed Microglia",NM_006343.2:665
CTSB-mRNA,-0.315,0.151,-0.61,-0.0198,0.804,0.655,0.986,0.0495,1,lm.nb,"Apoptosis, Autophagy, Microglia Neurodegenerative Phenotype (MGnD), Primed Microglia, Stage 1 DAM",NM_147780.2:1054
DNAJA2-mRNA,-0.516,0.249,-1,-0.0282,0.699,0.499,0.981,0.0513,1,lm.nb,Proteotoxic Stress,NM_005880.3:370
DMD-mRNA,0.216,0.105,0.0106,0.42,1.16,1.01,1.34,0.0525,1,lm.nb,"Blood Brain Barrier, Cytoskeletal Dynamics, Neurogenesis",NM_004014.2:1334
ATP6V1E1-mRNA,-0.471,0.229,-0.92,-0.0222,0.721,0.529,0.985,0.053,1,lm.nb,"Ion Transport, Phagocytosis",NM_001696.4:580
KCNAB1-mRNA,-0.473,0.231,-0.926,-0.0207,0.72,0.526,0.986,0.0538,1,lm.nb,Ion Transport,NM_003471.3:520
ADORA1-mRNA,0.345,0.169,0.0144,0.676,1.27,1.01,1.6,0.0542,1,lm.nb,"Neuroactive Ligands and Receptors, Purinergic Signaling",NM_000674.1:1150
ADAM22-mRNA,-0.649,0.319,-1.27,-0.0236,0.638,0.414,0.984,0.0554,1,lm.nb,"Cytoskeletal Dynamics, Myelogenesis",NM_021723.3:2290
C4A/B-mRNA,1,0.494,0.0361,1.97,2,1.03,3.92,0.0555,1,lm.nb,"Astrocyte Markers, Complement System, Cytoskeletal Dynamics",NM_007293.2:1217
NUAK1-mRNA,-0.573,0.283,-1.13,-0.0184,0.672,0.458,0.987,0.0564,1,lm.nb,Primed Microglia,NM_014840.2:1914
SEC23A-mRNA,-0.372,0.184,-0.733,-0.0114,0.773,0.602,0.992,0.0567,1,lm.nb,"Antigen Processing and Presentation, Proteotoxic Stress",NM_006364.2:1204
EPB41L3-mRNA,-0.534,0.266,-1.06,-0.0129,0.691,0.481,0.991,0.0583,1,lm.nb,"Cytoskeletal Dynamics, Myelogenesis",NM_012307.3:726
CYP2U1-mRNA,0.265,0.132,0.00642,0.524,1.2,1,1.44,0.0583,1,lm.nb,Lipid Metabolism,NM_183075.3:602
INPP5F-mRNA,-0.591,0.294,-1.17,-0.0142,0.664,0.445,0.99,0.0583,1,lm.nb,"Cytoskeletal Dynamics, Neurogenesis",NM_001243194.1:1018
DCLK1-mRNA,-0.682,0.341,-1.35,-0.0136,0.623,0.392,0.991,0.0593,1,lm.nb,Neurogenesis,NM_004734.4:1571
F11R-mRNA,-0.542,0.272,-1.08,-0.00831,0.687,0.474,0.994,0.0604,1,lm.nb,"Cell Migration, Microglial Markers, Primed Microglia",NM_016946.5:749
TJP1-mRNA,0.355,0.18,0.00279,0.707,1.28,1,1.63,0.0622,1,lm.nb,"Gap Junctions, Primed Microglia",NM_175610.2:4065
TIMP2-mRNA,0.381,0.193,0.00179,0.76,1.3,1,1.69,0.0629,1,lm.nb,"Neurogenesis, Stage 2 DAM",NM_003255.4:397
CYBB-mRNA,0.546,0.278,0.000341,1.09,1.46,1,2.13,0.0639,1,lm.nb,"Angiogenesis, Antigen Processing and Presentation, Hypoxia, Microglia Neurodegenerative Phenotype (MGnD), Oxidative & Nitrosative Stress, Primed Microglia",NM_000397.3:1034
PPP2R2B-mRNA,-0.322,0.164,-0.645,6.48E-05,0.8,0.64,1,0.0641,1,lm.nb,Dopaminergic Synapse,NM_181676.2:690
DYNC1LI1-mRNA,-0.449,0.23,-0.899,0.000792,0.732,0.536,1,0.0645,1,lm.nb,Antigen Processing and Presentation,NM_016141.3:1338
C1QC-mRNA,0.879,0.45,-0.00322,1.76,1.84,0.998,3.39,0.065,1,lm.nb,Complement System,NM_001114101.1:608
SEC61A2-mRNA,-0.358,0.183,-0.717,0.00149,0.78,0.609,1,0.0651,1,lm.nb,"Antigen Processing and Presentation, Proteotoxic Stress",NM_001142627.1:768
BRAF-mRNA,-0.183,0.0948,-0.369,0.00264,0.881,0.774,1,0.0676,1,lm.nb,MAPK & PI3K,NM_004333.3:565
RAB3A-mRNA,-0.694,0.36,-1.4,0.0108,0.618,0.379,1.01,0.0679,1,lm.nb,"GABAergic Synapse, Glutamatergic Synapse",NM_002866.4:177
PTK2B-mRNA,-0.548,0.286,-1.11,0.0133,0.684,0.464,1.01,0.0701,1,lm.nb,"Calcium Signaling, Cytoskeletal Dynamics, NO Metabolism and Signaling",NM_004103.3:735
ABCE1-mRNA,-0.241,0.126,-0.489,0.00615,0.846,0.713,1,0.0704,1,lm.nb,Interferon Signaling,NM_001040876.1:635
TNFRSF21-mRNA,-0.303,0.159,-0.615,0.0094,0.811,0.653,1.01,0.0718,1,lm.nb,"Cytokines, Oligodendrocyte DifferentiationMaturation",NM_014452.3:735
ATP6V1C1-mRNA,-0.465,0.247,-0.949,0.0188,0.725,0.518,1.01,0.0742,1,lm.nb,"Ion Transport, Phagocytosis, Primed Microglia",NM_001007254.1:800
TMEM47-mRNA,0.455,0.242,-0.0188,0.93,1.37,0.987,1.9,0.0744,1,lm.nb,Astrocyte Markers,NM_031442.4:700
IMMT-mRNA,-0.496,0.265,-1.01,0.0221,0.709,0.495,1.02,0.0752,1,lm.nb,Glucose Metabolism,NM_006839.2:2258
PGK1-mRNA,-0.354,0.19,-0.726,0.0177,0.782,0.604,1.01,0.0767,1,lm.nb,Glucose Metabolism,NM_000291.2:1030
TUSC3-mRNA,-0.567,0.305,-1.17,0.0307,0.675,0.446,1.02,0.0777,1,lm.nb,Proteotoxic Stress,NM_006765.2:1015
ATP1B1-mRNA,-0.623,0.338,-1.29,0.0398,0.649,0.41,1.03,0.0803,1,lm.nb,Ion Transport,NM_001677.3:190
GOT1-mRNA,-0.722,0.394,-1.5,0.0506,0.606,0.355,1.04,0.082,1,lm.nb,Glutamatergic Synapse,NM_002079.2:615
VDAC3-mRNA,-0.512,0.28,-1.06,0.0373,0.701,0.479,1.03,0.0827,1,lm.nb,Calcium Signaling,NM_001135694.2:870
IFNGR2-mRNA,-0.213,0.116,-0.441,0.0157,0.863,0.737,1.01,0.0829,1,lm.nb,Interferon Signaling,NM_005534.3:799
HILPDA-mRNA,-1.05,0.578,-2.19,0.0782,0.482,0.22,1.06,0.083,1,lm.nb,Astrocyte Markers,NM_013332.1:345
GABARAPL1-mRNA,-0.324,0.178,-0.672,0.0241,0.799,0.628,1.02,0.0831,1,lm.nb,"Autophagy, GABAergic Synapse",NM_031412.2:420
MAL2-mRNA,-0.582,0.32,-1.21,0.0457,0.668,0.432,1.03,0.0842,1,lm.nb,Myelogenesis,NM_052886.2:203
GNG2-mRNA,-0.566,0.313,-1.18,0.0471,0.675,0.441,1.03,0.0854,1,lm.nb,"Cannabinoid Signaling, Cholinergic Synapse, Dopaminergic Synapse, GABAergic Synapse, Glutamatergic Synapse, Primed Microglia, Serotonergic Synapse",NM_053064.5:396
ATP6V1B2-mRNA,-0.495,0.274,-1.03,0.043,0.71,0.489,1.03,0.0864,1,lm.nb,"Ion Transport, Phagocytosis, Primed Microglia",NM_001693.3:405
GABRG2-mRNA,-0.703,0.391,-1.47,0.0626,0.614,0.361,1.04,0.087,1,lm.nb,"Cannabinoid Signaling, GABAergic Synapse, Neuroactive Ligands and Receptors",NM_000816.3:872
GAD1-mRNA,-0.375,0.209,-0.786,0.0352,0.771,0.58,1.02,0.0883,1,lm.nb,GABAergic Synapse,NM_000817.2:575
PMP22-mRNA,0.371,0.208,-0.037,0.778,1.29,0.975,1.71,0.09,1,lm.nb,Myelogenesis,NM_000304.3:417
ELMO1-mRNA,-0.501,0.281,-1.05,0.0501,0.707,0.482,1.04,0.09,1,lm.nb,"Angiogenesis, Primed Microglia",NM_014800.10:2226
SOX2-mRNA,0.347,0.195,-0.0358,0.73,1.27,0.975,1.66,0.0908,1,lm.nb,Neurogenesis,NM_003106.3:1043
ARG2-mRNA,0.401,0.227,-0.0444,0.846,1.32,0.97,1.8,0.0929,1,lm.nb,NO Metabolism and Signaling,NM_001172.3:512
NSF-mRNA,-0.688,0.394,-1.46,0.0836,0.621,0.364,1.06,0.0959,1,lm.nb,GABAergic Synapse,NM_006178.3:1762
NMNAT2-mRNA,-0.562,0.323,-1.19,0.0698,0.677,0.437,1.05,0.0966,1,lm.nb,Cytoskeletal Dynamics,NM_170706.3:605
NPTN-mRNA,-0.382,0.22,-0.813,0.0483,0.767,0.569,1.03,0.0972,1,lm.nb,"Cytoskeletal Dynamics, Neurogenesis",NM_001161363.1:1022
GAS6-mRNA,0.266,0.154,-0.0352,0.567,1.2,0.976,1.48,0.0988,1,lm.nb,Neurogenesis,NM_000820.2:1339
DIAPH1-mRNA,-0.377,0.218,-0.805,0.0504,0.77,0.572,1.04,0.0992,1,lm.nb,Cell Migration,NM_005219.4:1398
HSPA9-mRNA,-0.196,0.114,-0.419,0.0266,0.873,0.748,1.02,0.0998,1,lm.nb,Primed Microglia,NM_004134.4:975
SERPINE2-mRNA,-0.411,0.238,-0.877,0.0559,0.752,0.544,1.04,0.0999,1,lm.nb,"Microglial Markers, Neurogenesis",NM_006216.2:240
BECN1-mRNA,-0.203,0.118,-0.435,0.0285,0.869,0.74,1.02,0.101,1,lm.nb,Autophagy,NM_003766.2:810
GABRA4-mRNA,-0.395,0.23,-0.846,0.0559,0.76,0.556,1.04,0.101,1,lm.nb,"Cannabinoid Signaling, GABAergic Synapse, Neuroactive Ligands and Receptors",NM_000809.2:1545
CD200-mRNA,-0.531,0.314,-1.15,0.085,0.692,0.452,1.06,0.107,1,lm.nb,Cytoskeletal Dynamics,NM_005944.5:665
RIMS1-mRNA,-0.58,0.346,-1.26,0.0968,0.669,0.418,1.07,0.109,1,lm.nb,"Cannabinoid Signaling, Cholinergic Synapse, Dopaminergic Synapse, GABAergic Synapse, Glutamatergic Synapse",NM_001168410.1:2305
NPAS2-mRNA,-0.262,0.157,-0.569,0.0452,0.834,0.674,1.03,0.11,1,lm.nb,Circadian Signaling,NM_002518.3:1458
ETV5-mRNA,-0.437,0.262,-0.951,0.0757,0.738,0.517,1.05,0.11,1,lm.nb,Neurogenesis,NM_004454.2:1685
NAP1L2-mRNA,-0.783,0.469,-1.7,0.137,0.581,0.307,1.1,0.111,1,lm.nb,Neurogenesis,NM_021963.4:908
REEP5-mRNA,-0.251,0.151,-0.547,0.0444,0.84,0.685,1.03,0.111,1,lm.nb,Primed Microglia,NM_005669.4:280
MAPK1-mRNA,-0.225,0.136,-0.491,0.0422,0.856,0.711,1.03,0.115,1,lm.nb,MAPK & PI3K,NM_138957.2:430
ENTPD1-mRNA,0.31,0.188,-0.0585,0.679,1.24,0.96,1.6,0.115,1,lm.nb,Purinergic Signaling,NM_001098175.1:795
UBE3C-mRNA,-0.169,0.103,-0.37,0.0328,0.89,0.774,1.02,0.116,1,lm.nb,Antigen Processing and Presentation,NM_014671.2:1222
RTN1-mRNA,-0.523,0.32,-1.15,0.104,0.696,0.451,1.07,0.117,1,lm.nb,Neurogenesis,NM_021136.2:2400
ATP1A1-mRNA,-0.523,0.32,-1.15,0.104,0.696,0.451,1.07,0.118,1,lm.nb,"Ion Transport, Primed Microglia",NM_000701.7:1550
SLC17A6-mRNA,-0.726,0.445,-1.6,0.146,0.604,0.33,1.11,0.118,1,lm.nb,"Cannabinoid Signaling, Glutamatergic Synapse",NM_020346.2:1555
ATP8A2-mRNA,-0.47,0.288,-1.04,0.095,0.722,0.488,1.07,0.119,1,lm.nb,"Microglial Markers, Neurogenesis, Primed Microglia",NM_016529.4:930
SLC38A1-mRNA,-0.416,0.255,-0.916,0.085,0.75,0.53,1.06,0.119,1,lm.nb,"GABAergic Synapse, Glutamatergic Synapse",NM_001077484.1:1766
MAPK8-mRNA,-0.283,0.174,-0.625,0.0589,0.822,0.649,1.04,0.12,1,lm.nb,MAPK & PI3K,NM_002750.2:945
GLRA3-mRNA,-0.419,0.259,-0.927,0.0881,0.748,0.526,1.06,0.121,1,lm.nb,Neuroactive Ligands and Receptors,NM_006529.3:492
RORB-mRNA,-0.433,0.269,-0.96,0.0935,0.741,0.514,1.07,0.123,1,lm.nb,"Circadian Signaling, Neurogenesis",NM_006914.3:1840
GMPR2-mRNA,-0.239,0.148,-0.53,0.0519,0.847,0.693,1.04,0.123,1,lm.nb,Primed Microglia,NM_001002001.2:392
CST3-mRNA,-0.49,0.305,-1.09,0.107,0.712,0.471,1.08,0.123,1,lm.nb,Homeostatic Microglia,NM_000099.2:402
PSMB8-mRNA,-0.498,0.312,-1.11,0.113,0.708,0.463,1.08,0.126,1,lm.nb,"A1 Astrocyte, Antigen Processing and Presentation, Interferon Signaling, Primed Microglia",NM_004159.4:1215
RECK-mRNA,0.182,0.114,-0.0418,0.406,1.13,0.971,1.33,0.127,1,lm.nb,Blood Brain Barrier,NM_021111.2:360
ATR-mRNA,-0.335,0.21,-0.747,0.0775,0.793,0.596,1.06,0.127,1,lm.nb,Cell Cycle,NM_001184.2:565
GPNMB-mRNA,0.63,0.399,-0.152,1.41,1.55,0.9,2.66,0.13,1,lm.nb,"Microglia Neurodegenerative Phenotype (MGnD), Primed Microglia",NM_001005340.1:535
NCAM2-mRNA,0.269,0.17,-0.065,0.602,1.2,0.956,1.52,0.13,1,lm.nb,"Cell Migration, Neurogenesis",NM_004540.4:1364
ATP2A2-mRNA,-0.189,0.12,-0.425,0.0467,0.877,0.745,1.03,0.132,1,lm.nb,"Calcium Signaling, Ion Transport",NM_001681.3:1396
EID1-mRNA,-0.247,0.157,-0.555,0.0615,0.843,0.681,1.04,0.132,1,lm.nb,Primed Microglia,NM_014335.3:413
WASF1-mRNA,-0.618,0.394,-1.39,0.154,0.652,0.381,1.11,0.132,1,lm.nb,"Angiogenesis, Phagocytosis",NM_001024934.1:1425
MBP-mRNA,0.701,0.449,-0.179,1.58,1.63,0.884,2.99,0.134,1,lm.nb,"Myelogenesis, Oligodendrocyte Markers",NM_002385.2:132
ATP5F1B-mRNA,-0.391,0.252,-0.885,0.102,0.763,0.542,1.07,0.136,1,lm.nb,Glucose Metabolism,NM_001686.3:645
SLC9A6-mRNA,-0.558,0.361,-1.27,0.149,0.679,0.416,1.11,0.138,1,lm.nb,Neurogenesis,NM_001042537.1:370
CD47-mRNA,-0.371,0.242,-0.845,0.103,0.773,0.557,1.07,0.141,1,lm.nb,NO Metabolism and Signaling,NM_001777.3:897
NDUFA10-mRNA,-0.205,0.134,-0.467,0.0575,0.868,0.724,1.04,0.142,1,lm.nb,Cannabinoid Signaling,NM_004544.3:876
ACOT13-mRNA,0.137,0.0899,-0.0389,0.314,1.1,0.973,1.24,0.142,1,lm.nb,Lipid Metabolism,NM_018473.2:400
CACNA2D3-mRNA,0.326,0.214,-0.0942,0.746,1.25,0.937,1.68,0.144,1,lm.nb,"Calcium Signaling, Ion Transport",NM_018398.2:205
ATG5-mRNA,-0.394,0.259,-0.903,0.114,0.761,0.535,1.08,0.144,1,lm.nb,Autophagy,NM_004849.2:1104
HSP90AB1-mRNA,-0.252,0.168,-0.581,0.0769,0.84,0.668,1.05,0.149,1,lm.nb,"Cytoskeletal Dynamics, Inflammasome, Proteotoxic Stress",NM_007355.3:1530
FIG4-mRNA,-0.207,0.138,-0.478,0.0634,0.866,0.718,1.04,0.149,1,lm.nb,"Myelogenesis, Neurogenesis",NM_014845.5:1060
GABRD-mRNA,-0.492,0.328,-1.13,0.151,0.711,0.455,1.11,0.15,1,lm.nb,"Cannabinoid Signaling, GABAergic Synapse, Neuroactive Ligands and Receptors",NM_000815.4:800
FBXL3-mRNA,0.186,0.125,-0.0588,0.431,1.14,0.96,1.35,0.152,1,lm.nb,"Antigen Processing and Presentation, Circadian Signaling",NM_012158.2:1565
DNAJC11-mRNA,-0.159,0.107,-0.368,0.0505,0.896,0.775,1.04,0.153,1,lm.nb,Glucose Metabolism,NM_018198.3:474
NF1-mRNA,-0.201,0.135,-0.466,0.0642,0.87,0.724,1.05,0.153,1,lm.nb,"Astrocyte DifferentiationFunction, MAPK & PI3K, Neurogenesis, Oligodendrocyte DifferentiationMaturation",NM_000267.2:1035
GRIK2-mRNA,-0.464,0.313,-1.08,0.149,0.725,0.474,1.11,0.154,1,lm.nb,"Glutamatergic Synapse, Neuroactive Ligands and Receptors",NM_021956.4:1329
CEP68-mRNA,-0.171,0.115,-0.397,0.0554,0.888,0.759,1.04,0.154,1,lm.nb,Primed Microglia,NM_015147.2:586
ASS1-mRNA,-0.369,0.25,-0.86,0.122,0.774,0.551,1.09,0.156,1,lm.nb,NO Metabolism and Signaling,NM_000050.4:1275
NKIRAS1-mRNA,-0.265,0.18,-0.618,0.0881,0.832,0.652,1.06,0.157,1,lm.nb,Cytokines,NM_020345.3:785
NEFL-mRNA,-0.635,0.433,-1.48,0.213,0.644,0.358,1.16,0.158,1,lm.nb,"Cytoskeletal Dynamics, Neurogenesis, Neuronal Markers",NM_006158.3:1112
FCGR3A/B-mRNA,0.535,0.365,-0.181,1.25,1.45,0.882,2.38,0.158,1,lm.nb,Phagocytosis,NM_000570.4:696
SCP2-mRNA,0.199,0.137,-0.0684,0.467,1.15,0.954,1.38,0.16,1,lm.nb,Lipid Metabolism,NM_001007100.2:405
GNG3-mRNA,-0.465,0.319,-1.09,0.16,0.724,0.47,1.12,0.161,1,lm.nb,"Cannabinoid Signaling, Cholinergic Synapse, Dopaminergic Synapse, GABAergic Synapse, Glutamatergic Synapse, Serotonergic Synapse",NM_012202.5:296
PARP2-mRNA,-0.288,0.198,-0.676,0.0995,0.819,0.626,1.07,0.161,1,lm.nb,Apoptosis,NM_005484.3:1154
PRKAB1-mRNA,-0.253,0.173,-0.593,0.0873,0.839,0.663,1.06,0.161,1,lm.nb,"Glucose Metabolism, Primed Microglia",NM_006253.4:471
RHOB-mRNA,0.441,0.305,-0.156,1.04,1.36,0.897,2.05,0.163,1,lm.nb,"Microglial Markers, Primed Microglia",NM_004040.2:870
RNF10-mRNA,-0.125,0.0861,-0.293,0.0443,0.917,0.816,1.03,0.164,1,lm.nb,"Myelogenesis, Neurogenesis",NM_014868.3:1910
RAD23B-mRNA,-0.154,0.107,-0.363,0.055,0.899,0.777,1.04,0.164,1,lm.nb,Proteotoxic Stress,NM_001244713.1:590
PIAS1-mRNA,0.137,0.0948,-0.049,0.323,1.1,0.967,1.25,0.164,1,lm.nb,"Interferon Signaling, JAK-STAT",NM_016166.1:1870
FTH1-mRNA,0.194,0.135,-0.0711,0.459,1.14,0.952,1.37,0.167,1,lm.nb,"Microglia Neurodegenerative Phenotype (MGnD), Stage 1 DAM",NM_002032.2:392
B4GALT6-mRNA,-0.438,0.306,-1.04,0.162,0.738,0.487,1.12,0.168,1,lm.nb,"Myelogenesis, Oligodendrocyte DifferentiationMaturation",NM_004775.3:930
HADH-mRNA,0.153,0.107,-0.0565,0.362,1.11,0.962,1.29,0.168,1,lm.nb,Lipid Metabolism,NM_001184705.2:645
TARDBP-mRNA,0.149,0.105,-0.0561,0.354,1.11,0.962,1.28,0.17,1,lm.nb,Proteotoxic Stress,NM_007375.3:476
CNTNAP2-mRNA,-0.553,0.39,-1.32,0.211,0.681,0.401,1.16,0.172,1,lm.nb,"Cell Migration, Cytoskeletal Dynamics, Myelogenesis",NM_014141.4:940
AKT1-mRNA,0.27,0.191,-0.104,0.643,1.21,0.93,1.56,0.173,1,lm.nb,MAPK & PI3K,NM_001014432.1:1275
DDAH1-mRNA,-0.247,0.176,-0.593,0.0989,0.843,0.663,1.07,0.177,1,lm.nb,NO Metabolism and Signaling,NM_012137.2:620
LTA4H-mRNA,-0.2,0.145,-0.485,0.084,0.87,0.715,1.06,0.183,1,lm.nb,Lipid Metabolism,NM_001256643.1:1140
YWHAH-mRNA,-0.582,0.427,-1.42,0.254,0.668,0.374,1.19,0.188,1,lm.nb,"Cell Cycle, Neurogenesis",NM_003405.3:552
CYFIP2-mRNA,-0.255,0.187,-0.622,0.112,0.838,0.65,1.08,0.188,1,lm.nb,"Angiogenesis, Neurogenesis",NM_001037333.1:2142
SYNGR1-mRNA,-0.239,0.178,-0.589,0.11,0.847,0.665,1.08,0.194,1,lm.nb,Neurogenesis,NM_145731.3:296
ATG2B-mRNA,0.14,0.105,-0.0648,0.345,1.1,0.956,1.27,0.195,1,lm.nb,Autophagy,NM_018036.5:1722
CHRNB2-mRNA,-0.46,0.344,-1.13,0.214,0.727,0.455,1.16,0.196,1,lm.nb,"Cholinergic Synapse, Neuroactive Ligands and Receptors",NM_000748.3:510
OLFM3-mRNA,-0.587,0.439,-1.45,0.274,0.666,0.366,1.21,0.196,1,lm.nb,Neurogenesis,NM_058170.3:1154
KLHL12-mRNA,-0.149,0.112,-0.369,0.0702,0.902,0.774,1.05,0.197,1,lm.nb,Wnt Signaling,NM_021633.2:474
CD44-mRNA,-1.02,0.768,-2.53,0.481,0.492,0.173,1.4,0.198,1,lm.nb,"Astrocyte Markers, Interferon Signaling, Primed Microglia",NM_001001392.1:429
TLN2-mRNA,-0.34,0.255,-0.839,0.16,0.79,0.559,1.12,0.198,1,lm.nb,Cell Migration,NM_015059.2:640
PROS1-mRNA,-0.39,0.293,-0.965,0.185,0.763,0.512,1.14,0.198,1,lm.nb,Complement System,NM_000313.1:875
APP-mRNA,-0.223,0.168,-0.551,0.106,0.857,0.682,1.08,0.199,1,lm.nb,"Astrocyte DifferentiationFunction, Cytoskeletal Dynamics, Neurogenesis, Serotonergic Synapse",NM_000484.3:1725
SNAP25-mRNA,-0.52,0.393,-1.29,0.25,0.697,0.409,1.19,0.2,1,lm.nb,"Cholinergic Synapse, Dopaminergic Synapse, GABAergic Synapse, Glutamatergic Synapse, Serotonergic Synapse",NM_003081.3:284
C9orf72-mRNA,-0.308,0.233,-0.765,0.149,0.808,0.588,1.11,0.201,1,lm.nb,"Autophagy, Cytoskeletal Dynamics",NM_145005.6:242
SKP1-mRNA,-0.146,0.111,-0.363,0.0709,0.904,0.777,1.05,0.202,1,lm.nb,"Cell Cycle, Circadian Signaling, Proteotoxic Stress, Wnt Signaling",NM_006930.3:318
SOD1-mRNA,0.174,0.132,-0.0847,0.433,1.13,0.943,1.35,0.202,1,lm.nb,"Myelogenesis, Neurogenesis, Oxidative & Nitrosative Stress",NM_000454.4:245
PFKP-mRNA,0.221,0.168,-0.108,0.551,1.17,0.928,1.46,0.203,1,lm.nb,"Astrocyte Markers, Glucose Metabolism",NM_002627.3:795
NLK-mRNA,-0.268,0.205,-0.67,0.133,0.83,0.629,1.1,0.205,1,lm.nb,Wnt Signaling,NM_016231.4:618
RAB6B-mRNA,-0.298,0.227,-0.743,0.148,0.814,0.597,1.11,0.205,1,lm.nb,Primed Microglia,NM_016577.3:620
CTSF-mRNA,0.121,0.0931,-0.0615,0.303,1.09,0.958,1.23,0.209,1,lm.nb,"Apoptosis, Microglial Markers",NM_003793.3:655
GABRB3-mRNA,-0.379,0.292,-0.95,0.193,0.769,0.518,1.14,0.209,1,lm.nb,"Cannabinoid Signaling, GABAergic Synapse, Neuroactive Ligands and Receptors, Serotonergic Synapse",NM_000814.5:448
AHCYL1-mRNA,-0.344,0.265,-0.863,0.175,0.788,0.55,1.13,0.209,1,lm.nb,"Angiogenesis, Astrocyte Markers",NM_001242674.1:1103
CX3CR1-mRNA,0.561,0.434,-0.29,1.41,1.47,0.818,2.66,0.211,1,lm.nb,"Chemokines, Homeostatic Microglia, Microglia Neurodegenerative Phenotype (MGnD), Microglial Markers, Primed Microglia, Stage 1 DAM",NM_001337.3:1040
BACE1-mRNA,-0.222,0.172,-0.56,0.116,0.858,0.678,1.08,0.213,1,lm.nb,Cytoskeletal Dynamics,NM_012104.4:1185
ATP9A-mRNA,-0.103,0.0807,-0.262,0.0549,0.931,0.834,1.04,0.215,1,lm.nb,Ion Transport,NM_006045.1:1200
DNM1L-mRNA,-0.231,0.181,-0.586,0.124,0.852,0.666,1.09,0.217,1,lm.nb,"Apoptosis, Neurogenesis",NM_001278463.1:1396
HAMP-mRNA,-1.05,0.832,-2.68,0.578,0.482,0.156,1.49,0.221,1,Wald,"Microglial Markers, TGF-Beta Signaling",NM_021175.2:99
CCNB1-mRNA,0.223,0.177,-0.124,0.569,1.17,0.918,1.48,0.223,1,lm.nb,Cell Cycle,NM_031966.3:1102
TGFBR1-mRNA,0.289,0.23,-0.163,0.74,1.22,0.893,1.67,0.225,1,lm.nb,"Microglia Neurodegenerative Phenotype (MGnD), Microglial Markers, Primed Microglia, TGF-Beta Signaling",NM_004612.2:1255
C1S-mRNA,-0.429,0.343,-1.1,0.243,0.743,0.466,1.18,0.225,1,lm.nb,Complement System,NM_001734.2:775
SCN8A-mRNA,-0.419,0.337,-1.08,0.241,0.748,0.473,1.18,0.228,1,lm.nb,"Ion Transport, Myelogenesis",NM_014191.2:945
GRM1-mRNA,0.372,0.299,-0.214,0.958,1.29,0.862,1.94,0.228,1,lm.nb,"Calcium Signaling, Cannabinoid Signaling, Glutamatergic Synapse, Neuroactive Ligands and Receptors",NM_000838.3:2055
MAP3K4-mRNA,-0.28,0.226,-0.723,0.162,0.823,0.606,1.12,0.229,1,lm.nb,MAPK & PI3K,NM_005922.2:1165
LPAR6-mRNA,0.349,0.282,-0.204,0.902,1.27,0.868,1.87,0.231,1,lm.nb,"Neuroactive Ligands and Receptors, Purinergic Signaling",NM_005767.3:1210
SYT4-mRNA,-0.512,0.416,-1.33,0.303,0.701,0.399,1.23,0.233,1,lm.nb,"Cytoskeletal Dynamics, Neurogenesis",NM_020783.3:1202
ORC3-mRNA,-0.232,0.189,-0.602,0.139,0.852,0.659,1.1,0.235,1,lm.nb,Cell Cycle,NM_181837.1:585
SUMO1-mRNA,-0.216,0.177,-0.563,0.131,0.861,0.677,1.09,0.236,1,lm.nb,Interferon Signaling,NM_003352.8:348
KITLG-mRNA,-0.247,0.203,-0.645,0.151,0.843,0.639,1.11,0.238,1,lm.nb,MAPK & PI3K,NM_003994.5:232
PPP3R1-mRNA,-0.391,0.322,-1.02,0.241,0.763,0.492,1.18,0.239,1,lm.nb,"Calcium Signaling, MAPK & PI3K",NM_000945.3:394
AP3M2-mRNA,-0.201,0.166,-0.526,0.125,0.87,0.694,1.09,0.241,1,lm.nb,Primed Microglia,NM_001134296.1:655
TPI1-mRNA,-0.215,0.18,-0.569,0.138,0.861,0.674,1.1,0.246,1,lm.nb,"Glucose Metabolism, Primed Microglia",NM_000365.5:153
FCGR1A/B-mRNA,0.451,0.379,-0.292,1.19,1.37,0.817,2.29,0.248,1,lm.nb,"Antigen Processing and Presentation, Cytokines, Interferon Signaling, Phagocytosis",NM_000566.3:842
ORC4-mRNA,-0.266,0.224,-0.706,0.174,0.832,0.613,1.13,0.25,1,lm.nb,Cell Cycle,NM_181742.1:871
S100A12-mRNA,0.677,0.573,-0.447,1.8,1.6,0.734,3.48,0.252,1,Wald,Cytokines,NM_005621.1:260
C1R-mRNA,-0.519,0.442,-1.39,0.347,0.698,0.383,1.27,0.254,1,lm.nb,Complement System,NM_001733.4:760
ADAR-mRNA,-0.0901,0.0767,-0.24,0.0603,0.939,0.846,1.04,0.254,1,lm.nb,Interferon Signaling,NM_001025107.1:3530
CTNNB1-mRNA,-0.134,0.114,-0.358,0.0907,0.912,0.78,1.06,0.257,1,lm.nb,Wnt Signaling,NM_001098210.1:1815
SLC7A8-mRNA,-0.313,0.27,-0.841,0.215,0.805,0.558,1.16,0.259,1,lm.nb,Ion Transport,NM_001267036.1:1172
ADGRG1-mRNA,-0.442,0.382,-1.19,0.307,0.736,0.438,1.24,0.261,1,lm.nb,"Microglia Neurodegenerative Phenotype (MGnD), Neurogenesis",NM_005682.4:1145
GNAS-mRNA,-0.218,0.189,-0.589,0.152,0.86,0.665,1.11,0.261,1,lm.nb,"Calcium Signaling, Dopaminergic Synapse, Glutamatergic Synapse, Microglia Neurodegenerative Phenotype (MGnD), Serotonergic Synapse",NM_080425.1:1910
VEGFA-mRNA,-0.5,0.436,-1.35,0.353,0.707,0.391,1.28,0.264,1,lm.nb,"Angiogenesis, Hypoxia, Microglia Neurodegenerative Phenotype (MGnD), Neurogenesis",NM_001025366.1:1325
ADORA3-mRNA,1.43,1.24,-1,3.86,2.69,0.498,14.5,0.264,1,Wald,"Neuroactive Ligands and Receptors, Purinergic Signaling",NM_000677.3:1524
DNM1-mRNA,-0.377,0.33,-1.02,0.27,0.77,0.492,1.21,0.267,1,lm.nb,"Antigen Processing and Presentation, Cytoskeletal Dynamics, Gap Junctions",NM_004408.2:817
KCNV1-mRNA,-0.681,0.596,-1.85,0.487,0.624,0.277,1.4,0.267,1,lm.nb,Ion Transport,NM_014379.2:1622
ATP6V1H-mRNA,-0.218,0.192,-0.595,0.159,0.86,0.662,1.12,0.271,1,lm.nb,"Ion Transport, Phagocytosis",NM_213620.1:490
CSF1-mRNA,0.356,0.317,-0.266,0.977,1.28,0.832,1.97,0.275,1,lm.nb,"Cytokines, Microglia Neurodegenerative Phenotype (MGnD), Primed Microglia, Stage 2 DAM",NM_000757.4:823
HLA-E-mRNA,-0.358,0.322,-0.99,0.273,0.78,0.503,1.21,0.279,1,lm.nb,"A1 Astrocyte, Antigen Processing and Presentation",NM_005516.5:330
CA2-mRNA,0.402,0.362,-0.308,1.11,1.32,0.808,2.16,0.28,1,lm.nb,"Cytoskeletal Dynamics, Oligodendrocyte Markers",NM_000067.2:575
HMGB1-mRNA,-0.128,0.115,-0.353,0.098,0.915,0.783,1.07,0.281,1,lm.nb,"Autophagy, Neurogenesis",NM_002128.4:208
GRB2-mRNA,-0.143,0.13,-0.397,0.111,0.906,0.759,1.08,0.283,1,lm.nb,"MAPK & PI3K, T-cell signaling",NM_002086.4:412
CAMK2G-mRNA,0.186,0.169,-0.145,0.517,1.14,0.904,1.43,0.284,1,lm.nb,Calcium Signaling,NM_001222.2:233
SERPINI1-mRNA,-0.369,0.336,-1.03,0.289,0.774,0.49,1.22,0.285,1,lm.nb,Neurogenesis,NM_005025.4:435
SLC12A2-mRNA,0.11,0.101,-0.0875,0.308,1.08,0.941,1.24,0.287,1,lm.nb,Ion Transport,NM_001046.2:1255
RBX1-mRNA,-0.103,0.0962,-0.292,0.0852,0.931,0.817,1.06,0.295,1,lm.nb,"Cell Cycle, Circadian Signaling, Hypoxia, Proteotoxic Stress, Wnt Signaling",NM_014248.2:162
GPHN-mRNA,-0.129,0.12,-0.364,0.107,0.915,0.777,1.08,0.297,1,lm.nb,GABAergic Synapse,NM_020806.4:1145
SRPRA-mRNA,-0.166,0.155,-0.469,0.138,0.892,0.722,1.1,0.298,1,lm.nb,Proteotoxic Stress,NM_001177842.1:1065
TRIM3-mRNA,-0.293,0.274,-0.831,0.245,0.816,0.562,1.18,0.298,1,lm.nb,Interferon Signaling,NM_006458.2:1880
CALM2-mRNA,-0.214,0.201,-0.608,0.18,0.862,0.656,1.13,0.299,1,lm.nb,Calcium Signaling,NM_001743.4:416
TRIM35-mRNA,-0.185,0.174,-0.525,0.155,0.88,0.695,1.11,0.3,1,lm.nb,Interferon Signaling,NM_171982.3:886
LRRC7-mRNA,-0.536,0.507,-1.53,0.457,0.689,0.346,1.37,0.303,1,lm.nb,"Cytoskeletal Dynamics, Neurogenesis",NM_020794.2:2382
PRKDC-mRNA,-0.106,0.101,-0.304,0.0908,0.929,0.81,1.06,0.303,1,lm.nb,Cell Cycle,NM_001081640.1:2762
SHC3-mRNA,-0.216,0.205,-0.617,0.185,0.861,0.652,1.14,0.304,1,lm.nb,Neurotrophin Signaling,NM_016848.5:925
CD163-mRNA,0.538,0.514,-0.469,1.54,1.45,0.722,2.92,0.308,1,lm.nb,,NM_004244.4:1630
GABRA1-mRNA,-0.322,0.308,-0.926,0.283,0.8,0.526,1.22,0.309,1,lm.nb,"Cannabinoid Signaling, GABAergic Synapse, Neuroactive Ligands and Receptors",NM_000806.5:475
MAPK10-mRNA,-0.281,0.27,-0.81,0.248,0.823,0.57,1.19,0.311,1,lm.nb,MAPK & PI3K,NM_138981.2:450
TMSB4X-mRNA,-0.118,0.114,-0.341,0.105,0.921,0.789,1.08,0.312,1,lm.nb,"Cytoskeletal Dynamics, Homeostatic Microglia",NM_021109.4:86
SELPLG-mRNA,1.22,1.18,-1.09,3.53,2.33,0.469,11.6,0.314,1,Wald,"Cell Migration, Microglial Markers, Primed Microglia",NM_001206609.1:326
HCN1-mRNA,-0.531,0.519,-1.55,0.487,0.692,0.342,1.4,0.319,1,lm.nb,Ion Transport,NM_021072.2:1450
HTR5A-mRNA,0.245,0.241,-0.228,0.718,1.19,0.854,1.64,0.322,1,lm.nb,"Calcium Signaling, Neuroactive Ligands and Receptors, Serotonergic Synapse",NM_024012.2:776
TFEC-mRNA,1.06,1.04,-0.988,3.1,2.08,0.504,8.58,0.324,1,Wald,Microglia Neurodegenerative Phenotype (MGnD),NM_012252.2:890
SLC9B2-mRNA,-0.224,0.223,-0.661,0.212,0.856,0.633,1.16,0.325,1,lm.nb,Ion Transport,NM_178833.4:1448
GRIN2A-mRNA,-0.261,0.26,-0.772,0.249,0.834,0.586,1.19,0.327,1,lm.nb,"Calcium Signaling, Dopaminergic Synapse, Glutamatergic Synapse, Neuroactive Ligands and Receptors",NM_000833.3:4497
ROCK2-mRNA,-0.15,0.15,-0.444,0.144,0.901,0.735,1.1,0.329,1,lm.nb,"Cell Migration, Wnt Signaling",NM_004850.3:3140
AIF1-mRNA,0.317,0.317,-0.305,0.939,1.25,0.809,1.92,0.33,1,lm.nb,"Microglial Markers, NO Metabolism and Signaling",NM_032955.1:185
ABCB1-mRNA,0.28,0.282,-0.272,0.833,1.21,0.828,1.78,0.332,1,lm.nb,Blood Brain Barrier,NM_000927.3:3910
ITGAX-mRNA,1.13,1.14,-1.1,3.37,2.19,0.467,10.3,0.332,1,Wald,"Microglia Neurodegenerative Phenotype (MGnD), Primed Microglia, Stage 2 DAM",NM_000887.4:1128
CYP4X1-mRNA,-0.238,0.24,-0.709,0.233,0.848,0.612,1.18,0.334,1,lm.nb,Serotonergic Synapse,NM_178033.1:810
CTSL-mRNA,-0.272,0.276,-0.812,0.269,0.828,0.569,1.2,0.336,1,lm.nb,"Apoptosis, Autophagy, Microglia Neurodegenerative Phenotype (MGnD), Stage 2 DAM",NM_001912.4:1072
CUL1-mRNA,-0.142,0.145,-0.426,0.141,0.906,0.745,1.1,0.337,1,lm.nb,"Antigen Processing and Presentation, Cell Cycle, Circadian Signaling, Primed Microglia, Proteotoxic Stress, Wnt Signaling",NM_003592.2:1487
INA-mRNA,-0.366,0.373,-1.1,0.365,0.776,0.467,1.29,0.338,1,lm.nb,Cytoskeletal Dynamics,NM_032727.4:1270
PNOC-mRNA,-0.961,0.979,-2.88,0.957,0.514,0.136,1.94,0.339,1,Wald,Cytoskeletal Dynamics,NM_001284244.1:416
PRKACB-mRNA,-0.206,0.213,-0.624,0.212,0.867,0.649,1.16,0.345,1,lm.nb,"Calcium Signaling, MAPK & PI3K, Wnt Signaling",NM_182948.2:805
PSMD6-mRNA,-0.0987,0.103,-0.3,0.102,0.934,0.812,1.07,0.348,1,lm.nb,Antigen Processing and Presentation,NM_001271779.1:1045
GLA-mRNA,0.0968,0.101,-0.101,0.294,1.07,0.933,1.23,0.348,1,lm.nb,NO Metabolism and Signaling,NM_000169.2:980
SLC17A7-mRNA,-0.272,0.284,-0.829,0.286,0.828,0.563,1.22,0.351,1,lm.nb,"Cannabinoid Signaling, Glutamatergic Synapse, Neuronal Markers",NM_020309.2:1330
TRIM37-mRNA,-0.253,0.265,-0.773,0.267,0.839,0.585,1.2,0.351,1,lm.nb,Antigen Processing and Presentation,NM_015294.4:1910
SAMM50-mRNA,-0.104,0.11,-0.32,0.113,0.93,0.801,1.08,0.358,1,lm.nb,Glucose Metabolism,NM_015380.4:890
ATP2B2-mRNA,-0.205,0.219,-0.634,0.223,0.867,0.644,1.17,0.359,1,lm.nb,"Calcium Signaling, Ion Transport",NM_001001331.2:426
IFIT1-mRNA,0.275,0.295,-0.303,0.853,1.21,0.811,1.81,0.362,1,lm.nb,Interferon Signaling,NM_001548.3:1440
UCHL1-mRNA,-0.331,0.357,-1.03,0.369,0.795,0.489,1.29,0.365,1,lm.nb,"Cytoskeletal Dynamics, Neurogenesis",NM_004181.4:579
BAX-mRNA,0.124,0.134,-0.139,0.388,1.09,0.908,1.31,0.366,1,lm.nb,"Apoptosis, Proteotoxic Stress",NM_138761.3:342
UNC80-mRNA,-0.235,0.256,-0.737,0.266,0.849,0.6,1.2,0.369,1,lm.nb,Ion Transport,NM_032504.1:3056
CAMK2A-mRNA,-0.231,0.253,-0.727,0.264,0.852,0.604,1.2,0.371,1,lm.nb,Calcium Signaling,NM_001363989.1:1392
PSEN1-mRNA,0.189,0.207,-0.216,0.594,1.14,0.861,1.51,0.372,1,lm.nb,"Astrocyte DifferentiationFunction, Neurogenesis, Neurotrophin Signaling, Wnt Signaling",NM_000021.2:900
MAPT-mRNA,0.163,0.179,-0.187,0.513,1.12,0.878,1.43,0.372,1,lm.nb,"Astrocyte DifferentiationFunction, Cytoskeletal Dynamics, Neurogenesis",NM_016834.4:315
JAK1-mRNA,0.104,0.114,-0.12,0.329,1.08,0.92,1.26,0.372,1,lm.nb,JAK-STAT,NM_002227.1:285
SLC25A12-mRNA,-0.255,0.28,-0.804,0.294,0.838,0.573,1.23,0.374,1,lm.nb,Myelogenesis,NM_003705.5:435
CTSD-mRNA,0.094,0.103,-0.109,0.297,1.07,0.927,1.23,0.374,1,lm.nb,"Apoptosis, Autophagy, Homeostatic Microglia, Microglia Neurodegenerative Phenotype (MGnD), Microglial Markers, Stage 1 DAM",NM_001909.4:1270
TENM4-mRNA,-0.151,0.167,-0.478,0.175,0.901,0.718,1.13,0.375,1,lm.nb,"Myelogenesis, Neurogenesis, Oligodendrocyte DifferentiationMaturation",NM_001098816.3:5518
IFNAR1-mRNA,-0.12,0.134,-0.383,0.142,0.92,0.767,1.1,0.38,1,lm.nb,Interferon Signaling,NM_000629.2:782
PGAM1-mRNA,-0.0845,0.0943,-0.269,0.1,0.943,0.83,1.07,0.381,1,lm.nb,Glucose Metabolism,NM_002629.3:439
DUSP3-mRNA,-0.105,0.118,-0.337,0.126,0.93,0.792,1.09,0.383,1,lm.nb,"MAPK & PI3K, Neurotrophin Signaling",NM_004090.3:159
PRKCD-mRNA,-0.217,0.244,-0.695,0.261,0.86,0.618,1.2,0.384,1,lm.nb,"Neurotrophin Signaling, Phagocytosis",NM_006254.3:2165
NRXN1-mRNA,-0.309,0.349,-0.993,0.374,0.807,0.503,1.3,0.385,1,lm.nb,"Cell Migration, Neurogenesis",NM_001320156.1:364
AQP4-mRNA,0.207,0.235,-0.254,0.667,1.15,0.839,1.59,0.389,1,lm.nb,Astrocyte Markers,NM_004028.4:1169
UBQLN1-mRNA,-0.125,0.142,-0.403,0.154,0.917,0.756,1.11,0.391,1,lm.nb,Proteotoxic Stress,NM_053067.2:990
CX3CL1-mRNA,0.335,0.383,-0.416,1.09,1.26,0.749,2.12,0.392,1,lm.nb,Chemokines,NM_002996.4:1080
NCKAP1-mRNA,-0.167,0.192,-0.544,0.209,0.891,0.686,1.16,0.395,1,lm.nb,"Angiogenesis, Neurogenesis",NM_013436.3:2353
FGF2-mRNA,-0.299,0.344,-0.973,0.375,0.813,0.509,1.3,0.395,1,lm.nb,"Cytokines, MAPK & PI3K",NM_002006.4:620
CD84-mRNA,0.753,0.876,-0.964,2.47,1.68,0.513,5.54,0.401,1,Wald,Primed Microglia,NM_003874.3:680
SYT1-mRNA,-0.325,0.378,-1.07,0.417,0.799,0.478,1.34,0.401,1,lm.nb,"Cholinergic Synapse, Dopaminergic Synapse, GABAergic Synapse, Glutamatergic Synapse, Neurogenesis, Neuronal Markers, Serotonergic Synapse",NM_005639.2:1736
OPCML-mRNA,-0.271,0.317,-0.892,0.349,0.828,0.539,1.27,0.401,1,lm.nb,Neurogenesis,NM_002545.4:873
GABRA3-mRNA,-0.284,0.331,-0.933,0.365,0.822,0.524,1.29,0.402,1,lm.nb,"Cannabinoid Signaling, GABAergic Synapse, Neuroactive Ligands and Receptors",NM_000808.3:241
ITM2A-mRNA,0.199,0.236,-0.264,0.661,1.15,0.833,1.58,0.409,1,lm.nb,Blood Brain Barrier,NM_004867.4:988
SYN2-mRNA,-0.331,0.394,-1.1,0.44,0.795,0.466,1.36,0.41,1,lm.nb,"Dopaminergic Synapse, Serotonergic Synapse",NM_003178.5:1292
SYN1-mRNA,-0.252,0.299,-0.839,0.335,0.84,0.559,1.26,0.41,1,lm.nb,"Cytoskeletal Dynamics, Dopaminergic Synapse, Neurogenesis, Neuronal Markers, Serotonergic Synapse",NM_006950.3:565
FBXW11-mRNA,0.0973,0.117,-0.132,0.326,1.07,0.913,1.25,0.415,1,lm.nb,"Antigen Processing and Presentation, Circadian Signaling, Wnt Signaling",NM_033644.2:740
PTK2-mRNA,0.0681,0.0825,-0.0936,0.23,1.05,0.937,1.17,0.419,1,lm.nb,Cell Migration,NM_005607.5:2431
HECTD1-mRNA,-0.0869,0.106,-0.294,0.12,0.942,0.816,1.09,0.42,1,lm.nb,Antigen Processing and Presentation,NM_015382.2:810
RET-mRNA,-0.714,0.876,-2.43,1,0.609,0.185,2,0.425,1,Wald,Neurogenesis,NM_020630.4:2911
ADH5-mRNA,-0.0827,0.102,-0.282,0.116,0.944,0.823,1.08,0.425,1,lm.nb,Lipid Metabolism,NM_000671.3:832
TAP1-mRNA,-0.891,1.1,-3.05,1.27,0.539,0.12,2.41,0.429,1,Wald,"Antigen Processing and Presentation, Primed Microglia",NM_000593.5:2075
KHSRP-mRNA,-0.0597,0.0751,-0.207,0.0876,0.959,0.866,1.06,0.436,1,loglinear,Proteotoxic Stress,NM_001366299.1:900
TMEM88B-mRNA,0.894,1.13,-1.31,3.1,1.86,0.402,8.59,0.437,1,Wald,,NM_001146685.1:222
MS4A4A-mRNA,0.353,0.447,-0.523,1.23,1.28,0.696,2.34,0.439,1,lm.nb,,NM_001243266.1:296
CALM1-mRNA,-0.14,0.178,-0.488,0.208,0.907,0.713,1.16,0.44,1,lm.nb,Calcium Signaling,NM_006888.4:299
SCN1A-mRNA,-0.388,0.494,-1.36,0.58,0.764,0.391,1.49,0.441,1,lm.nb,"Dopaminergic Synapse, Ion Transport",NM_006920.4:995
SPARC-mRNA,0.256,0.328,-0.387,0.9,1.19,0.765,1.87,0.444,1,lm.nb,"Homeostatic Microglia, Primed Microglia",NM_003118.3:974
MAP2K4-mRNA,-0.15,0.193,-0.527,0.228,0.901,0.694,1.17,0.446,1,lm.nb,MAPK & PI3K,NM_003010.2:771
MAPK14-mRNA,-0.107,0.137,-0.375,0.162,0.929,0.771,1.12,0.446,1,lm.nb,MAPK & PI3K,NM_001315.2:792
CHCHD3-mRNA,0.0623,0.0809,-0.0963,0.221,1.04,0.935,1.17,0.45,1,lm.nb,Glucose Metabolism,NM_017812.2:206
GLS-mRNA,-0.196,0.257,-0.7,0.308,0.873,0.616,1.24,0.455,1,lm.nb,"GABAergic Synapse, Glutamatergic Synapse",NM_014905.3:985
GLRB-mRNA,-0.256,0.337,-0.916,0.404,0.837,0.53,1.32,0.455,1,lm.nb,Neuroactive Ligands and Receptors,NM_000824.4:355
PANX1-mRNA,0.0925,0.122,-0.146,0.331,1.07,0.904,1.26,0.456,1,lm.nb,Inflammasome,NM_015368.3:610
GNAI1-mRNA,-0.182,0.24,-0.652,0.289,0.882,0.636,1.22,0.458,1,lm.nb,"Cannabinoid Signaling, Cholinergic Synapse, Dopaminergic Synapse, GABAergic Synapse, Glutamatergic Synapse, Serotonergic Synapse",NM_002069.4:670
AMIGO2-mRNA,-0.853,1.13,-3.07,1.36,0.554,0.119,2.57,0.459,1,Wald,A1 Astrocyte,NM_001143668.1:1525
C3AR1-mRNA,1.01,1.35,-1.63,3.66,2.02,0.324,12.6,0.461,1,Wald,"Complement System, Neuroactive Ligands and Receptors, Primed Microglia",NM_004054.2:415
PPM1L-mRNA,-0.171,0.228,-0.619,0.276,0.888,0.651,1.21,0.462,1,lm.nb,Primed Microglia,NM_139245.2:984
SUGT1-mRNA,-0.073,0.0991,-0.267,0.121,0.951,0.831,1.09,0.47,1,lm.nb,Inflammasome,NM_001130912.1:1180
GRIA4-mRNA,-0.181,0.245,-0.662,0.3,0.882,0.632,1.23,0.47,1,lm.nb,"Cannabinoid Signaling, Dopaminergic Synapse, Glutamatergic Synapse, Neuroactive Ligands and Receptors",NM_000829.3:475
CUL2-mRNA,0.0875,0.12,-0.148,0.323,1.06,0.903,1.25,0.475,1,lm.nb,"Antigen Processing and Presentation, Hypoxia",NM_003591.2:1395
EIF2AK1-mRNA,-0.089,0.123,-0.33,0.152,0.94,0.795,1.11,0.478,1,lm.nb,Proteotoxic Stress,NM_014413.2:1685
S100A10-mRNA,-0.304,0.425,-1.14,0.529,0.81,0.455,1.44,0.483,1,lm.nb,A2 Astrocyte,NM_002966.1:245
PDE1A-mRNA,-0.304,0.429,-1.14,0.536,0.81,0.453,1.45,0.487,1,lm.nb,Calcium Signaling,NM_005019.3:1500
GPR17-mRNA,0.887,1.25,-1.57,3.34,1.85,0.338,10.1,0.487,1,Wald,"Oligodendrocyte DifferentiationMaturation, Purinergic Signaling",NM_001161415.1:774
C1QB-mRNA,0.718,1.03,-1.3,2.73,1.64,0.407,6.65,0.493,1,Wald,"Complement System, Homeostatic Microglia",NM_000491.3:819
ASNS-mRNA,-0.144,0.207,-0.55,0.263,0.905,0.683,1.2,0.497,1,lm.nb,Proteotoxic Stress,NM_183356.2:1644
ABCA1-mRNA,0.256,0.369,-0.469,0.98,1.19,0.723,1.97,0.497,1,lm.nb,Lipid Metabolism,NM_005502.3:4048
GJD2-mRNA,-0.849,1.23,-3.26,1.56,0.555,0.105,2.95,0.498,1,Wald,Gap Junctions,NM_020660.2:826
WDR35-mRNA,-0.0918,0.134,-0.353,0.17,0.938,0.783,1.13,0.5,1,lm.nb,NO Metabolism and Signaling,NM_001006657.1:1400
RANBP9-mRNA,-0.125,0.184,-0.486,0.236,0.917,0.714,1.18,0.505,1,lm.nb,Neurogenesis,NM_005493.2:2000
CDK5R1-mRNA,-0.136,0.202,-0.533,0.26,0.91,0.691,1.2,0.509,1,lm.nb,"Cytoskeletal Dynamics, Neurogenesis, Neurotrophin Signaling",NM_003885.2:418
ANKH-mRNA,0.0906,0.138,-0.179,0.36,1.06,0.883,1.28,0.518,1,lm.nb,Primed Microglia,NM_054027.4:610
SH3GL2-mRNA,-0.301,0.457,-1.2,0.595,0.812,0.436,1.51,0.518,1,lm.nb,"Antigen Processing and Presentation, Neurogenesis",NM_003026.2:381
XK-mRNA,-0.17,0.26,-0.68,0.339,0.889,0.624,1.26,0.519,1,lm.nb,Neurogenesis,NM_021083.2:545
GRIA3-mRNA,-0.145,0.221,-0.579,0.288,0.904,0.67,1.22,0.519,1,lm.nb,"Cannabinoid Signaling, Dopaminergic Synapse, Glutamatergic Synapse, Neuroactive Ligands and Receptors",NM_000828.4:426
SPTAN1-mRNA,0.0761,0.116,-0.152,0.304,1.05,0.9,1.23,0.52,1,lm.nb,Neurogenesis,NM_001130438.1:6830
ARL6IP5-mRNA,0.0831,0.129,-0.169,0.335,1.06,0.889,1.26,0.526,1,lm.nb,Glutamatergic Synapse,NM_006407.4:210
CHRM3-mRNA,-0.267,0.416,-1.08,0.548,0.831,0.472,1.46,0.528,1,lm.nb,"Calcium Signaling, Cholinergic Synapse, Neuroactive Ligands and Receptors",NM_000740.2:1345
BUB3-mRNA,-0.0931,0.146,-0.378,0.192,0.938,0.769,1.14,0.53,1,lm.nb,Cell Cycle,NM_004725.3:775
GDPD2-mRNA,0.732,1.15,-1.52,2.99,1.66,0.348,7.93,0.532,1,Wald,,NM_001171191.1:1666
DRD1-mRNA,0.191,0.302,-0.4,0.783,1.14,0.758,1.72,0.533,1,lm.nb,"Astrocyte DifferentiationFunction, Calcium Signaling, Dopaminergic Synapse, Neuroactive Ligands and Receptors",NM_000794.3:1970
NOS1AP-mRNA,0.159,0.251,-0.333,0.652,1.12,0.794,1.57,0.534,1,lm.nb,"NO Metabolism and Signaling, Oxidative & Nitrosative Stress",NM_014697.3:1706
GABRA5-mRNA,-0.219,0.348,-0.901,0.464,0.859,0.535,1.38,0.537,1,lm.nb,"Cannabinoid Signaling, GABAergic Synapse, Neuroactive Ligands and Receptors",NM_000810.3:1054
PMEPA1-mRNA,-0.155,0.249,-0.643,0.333,0.898,0.641,1.26,0.541,1,lm.nb,TGF-Beta Signaling,NM_199171.2:254
MX1-mRNA,-0.108,0.179,-0.459,0.244,0.928,0.727,1.18,0.555,1,lm.nb,Interferon Signaling,NM_002462.2:1485
MYO5A-mRNA,-0.198,0.332,-0.849,0.453,0.872,0.555,1.37,0.557,1,lm.nb,"Cytoskeletal Dynamics, Myelogenesis",NM_000259.1:5090
SLC1A3-mRNA,-0.146,0.245,-0.627,0.335,0.903,0.647,1.26,0.557,1,lm.nb,Glutamatergic Synapse,NM_004172.4:558
LAMP1-mRNA,0.105,0.176,-0.241,0.451,1.08,0.846,1.37,0.558,1,lm.nb,Autophagy,NM_005561.3:730
PTPRZ1-mRNA,-0.164,0.276,-0.704,0.376,0.893,0.614,1.3,0.559,1,lm.nb,"Astrocyte Markers, Myelogenesis, Oligodendrocyte DifferentiationMaturation",NM_002851.2:2380
ENO2-mRNA,-0.188,0.318,-0.811,0.435,0.878,0.57,1.35,0.561,1,lm.nb,"Glucose Metabolism, Hypoxia, Neuronal Markers",NM_001975.2:1420
BTRC-mRNA,-0.0741,0.125,-0.32,0.172,0.95,0.801,1.13,0.561,1,lm.nb,"Antigen Processing and Presentation, T-cell signaling, Wnt Signaling",NM_001256856.1:1004
MAP1LC3B-mRNA,-0.0475,0.0809,-0.206,0.111,0.968,0.867,1.08,0.564,1,lm.nb,Autophagy,NM_022818.5:153
ENTPD2-mRNA,0.694,1.19,-1.64,3.03,1.62,0.32,8.18,0.567,1,Wald,Purinergic Signaling,NM_203468.1:206
GAD2-mRNA,0.14,0.241,-0.332,0.612,1.1,0.794,1.53,0.568,1,lm.nb,GABAergic Synapse,NM_000818.2:1245
SCD5-mRNA,0.131,0.228,-0.317,0.579,1.09,0.803,1.49,0.573,1,lm.nb,Lipid Metabolism,NM_024906.2:512
SLC24A3-mRNA,-0.15,0.263,-0.666,0.366,0.901,0.63,1.29,0.575,1,lm.nb,Primed Microglia,NM_020689.3:780
PDPK1-mRNA,0.0905,0.162,-0.226,0.407,1.06,0.855,1.33,0.582,1,lm.nb,"Cell Migration, Insulin Signaling, Neurotrophin Signaling, T-cell signaling",XM_011522521.2:4552
CSF3R-mRNA,0.999,1.8,-2.53,4.53,2,0.173,23.1,0.586,1,Wald,Cytokines,NM_000760.3:2066
RAPGEF2-mRNA,-0.0965,0.175,-0.44,0.247,0.935,0.737,1.19,0.588,1,lm.nb,MAPK & PI3K,NM_014247.2:3445
HACD3-mRNA,-0.064,0.117,-0.292,0.164,0.957,0.817,1.12,0.589,1,lm.nb,Lipid Metabolism,NM_016395.2:235
STAT3-mRNA,-0.145,0.27,-0.674,0.385,0.905,0.627,1.31,0.598,1,lm.nb,"JAK-STAT, Neurogenesis",NM_003150.3:2060
TMEM100-mRNA,0.688,1.28,-1.83,3.2,1.61,0.282,9.21,0.598,1,Wald,Astrocyte Markers,NM_018286.2:655
PIK3R1-mRNA,0.0749,0.14,-0.2,0.35,1.05,0.87,1.27,0.6,1,lm.nb,MAPK & PI3K,NM_181504.2:1105
PPM1A-mRNA,-0.093,0.174,-0.435,0.249,0.938,0.74,1.19,0.6,1,lm.nb,MAPK & PI3K,NM_021003.4:550
HLA-A-mRNA,-0.174,0.327,-0.815,0.466,0.886,0.569,1.38,0.6,1,lm.nb,"A1 Astrocyte, Antigen Processing and Presentation",NM_002116.5:1000
ITPR1-mRNA,-0.163,0.308,-0.768,0.441,0.893,0.587,1.36,0.603,1,lm.nb,"Apoptosis, Calcium Signaling",NM_001099952.2:4818
MBTPS1-mRNA,-0.0706,0.134,-0.333,0.191,0.952,0.794,1.14,0.603,1,lm.nb,Proteotoxic Stress,NM_003791.2:1434
CHN1-mRNA,-0.156,0.297,-0.737,0.425,0.898,0.6,1.34,0.605,1,lm.nb,Neurogenesis,NM_001025201.3:1018
SERPING1-mRNA,-0.189,0.362,-0.898,0.521,0.877,0.537,1.43,0.608,1,lm.nb,"A1 Astrocyte, Complement System",NM_000062.2:305
PCCA-mRNA,0.0747,0.144,-0.208,0.357,1.05,0.866,1.28,0.61,1,lm.nb,Lipid Metabolism,NM_000282.3:1022
STMN1-mRNA,-0.122,0.236,-0.583,0.34,0.919,0.667,1.27,0.611,1,lm.nb,"MAPK & PI3K, Neurogenesis, Neuronal Markers",NM_203401.1:478
ACADM-mRNA,0.053,0.103,-0.148,0.254,1.04,0.902,1.19,0.611,1,lm.nb,Lipid Metabolism,NM_000016.5:1289
PTGS2-mRNA,-0.867,1.68,-4.16,2.43,0.548,0.0559,5.38,0.612,1,Wald,"A2 Astrocyte, Cannabinoid Signaling, Lipid Metabolism, NF-kappaB Signaling, NO Metabolism and Signaling, Serotonergic Synapse",NM_000963.1:495
TRIM26-mRNA,0.0895,0.176,-0.255,0.434,1.06,0.838,1.35,0.616,1,lm.nb,"Interferon Signaling, Primed Microglia",NM_001242783.1:860
AGMO-mRNA,0.53,1.05,-1.53,2.59,1.44,0.346,6.02,0.62,1,Wald,Lipid Metabolism,NM_001004320.1:320
ATF2-mRNA,0.0435,0.0874,-0.128,0.215,1.03,0.915,1.16,0.624,1,lm.nb,"Cytokines, Dopaminergic Synapse, MAPK & PI3K",NM_001256091.1:668
ESAM-mRNA,0.129,0.261,-0.382,0.641,1.09,0.767,1.56,0.626,1,lm.nb,"Blood Brain Barrier, Cell Migration",NM_138961.2:715
FGF13-mRNA,-0.124,0.254,-0.622,0.375,0.918,0.65,1.3,0.631,1,lm.nb,"Cytoskeletal Dynamics, Neurogenesis",NM_001139498.1:410
PRKCE-mRNA,-0.108,0.222,-0.543,0.328,0.928,0.686,1.26,0.633,1,lm.nb,Phagocytosis,NM_005400.2:1138
TLR2-mRNA,0.849,1.76,-2.59,4.29,1.8,0.166,19.6,0.634,1,Wald,"NO Metabolism and Signaling, Oligodendrocyte DifferentiationMaturation, Primed Microglia",NM_003264.3:2402
PRKAB2-mRNA,0.0986,0.206,-0.305,0.502,1.07,0.81,1.42,0.637,1,lm.nb,"Glucose Metabolism, Lipid Metabolism",NM_005399.5:712
MTMR4-mRNA,-0.0639,0.134,-0.326,0.199,0.957,0.798,1.15,0.638,1,lm.nb,Autophagy,NM_004687.4:1098
TRIM2-mRNA,0.068,0.143,-0.212,0.348,1.05,0.864,1.27,0.639,1,lm.nb,"Interferon Signaling, Primed Microglia",NM_001302694.1:298
P2RY12-mRNA,0.168,0.354,-0.526,0.862,1.12,0.695,1.82,0.64,1,lm.nb,"Homeostatic Microglia, Microglia Neurodegenerative Phenotype (MGnD), Microglial Markers, Primed Microglia, Purinergic Signaling, Stage 1 DAM",NM_022788.3:230
TIAM1-mRNA,0.111,0.234,-0.348,0.569,1.08,0.786,1.48,0.641,1,lm.nb,"Cytoskeletal Dynamics, Neurogenesis, Neurotrophin Signaling",NM_001353691.1:4520
IFIT3-mRNA,-0.436,0.921,-2.24,1.37,0.739,0.212,2.58,0.641,1,Wald,Interferon Signaling,NM_001031683.2:1470
PTH2R-mRNA,-0.514,1.09,-2.65,1.62,0.7,0.16,3.07,0.642,1,Wald,Neuroactive Ligands and Receptors,NM_001371906.1:1170
PTPN11-mRNA,-0.0396,0.0845,-0.205,0.126,0.973,0.867,1.09,0.644,1,lm.nb,"Interferon Signaling, Neurogenesis, Neurotrophin Signaling",NM_002834.3:1480
TANC2-mRNA,-0.082,0.175,-0.426,0.262,0.945,0.745,1.2,0.645,1,lm.nb,Cytoskeletal Dynamics,NM_025185.3:2490
LAIR1-mRNA,0.565,1.22,-1.82,2.95,1.48,0.283,7.73,0.648,1,Wald,T-cell signaling,NM_001289023.2:864
CLDN5-mRNA,0.152,0.332,-0.5,0.804,1.11,0.707,1.75,0.652,1,lm.nb,"Blood Brain Barrier, Cell Migration, Myelogenesis",NM_001130861.1:1422
CLEC7A-mRNA,0.647,1.42,-2.15,3.44,1.57,0.226,10.8,0.655,1,Wald,"Microglia Neurodegenerative Phenotype (MGnD), Primed Microglia, Stage 2 DAM",NM_197954.3:78
GRIA1-mRNA,-0.12,0.265,-0.64,0.4,0.92,0.642,1.32,0.656,1,lm.nb,"Cannabinoid Signaling, Dopaminergic Synapse, Glutamatergic Synapse, Neuroactive Ligands and Receptors",NM_000827.3:2840
MAP2K1-mRNA,-0.105,0.237,-0.57,0.36,0.93,0.673,1.28,0.661,1,lm.nb,MAPK & PI3K,NM_002755.3:1174
HDAC2-mRNA,-0.0836,0.189,-0.455,0.288,0.944,0.73,1.22,0.664,1,lm.nb,"Cell Cycle, Neurogenesis, Oligodendrocyte DifferentiationMaturation",NM_001527.1:930
LRRC25-mRNA,0.448,1.02,-1.54,2.44,1.36,0.344,5.42,0.664,1,Wald,,NM_145256.2:796
TMEM119-mRNA,0.972,2.21,-3.36,5.3,1.96,0.0974,39.5,0.665,1,Wald,"Microglia Neurodegenerative Phenotype (MGnD), Microglial Markers, Primed Microglia, Stage 1 DAM",NM_181724.2:415
PECAM1-mRNA,-0.148,0.341,-0.816,0.52,0.902,0.568,1.43,0.668,1,lm.nb,"Blood Brain Barrier, Cell Migration",NM_000442.3:1365
CD34-mRNA,0.136,0.315,-0.481,0.753,1.1,0.717,1.68,0.67,1,lm.nb,Cell Migration,NM_001025109.1:650
SLC12A5-mRNA,-0.115,0.268,-0.641,0.41,0.923,0.641,1.33,0.672,1,lm.nb,"GABAergic Synapse, Neurogenesis",NM_001134771.1:2825
TLR7-mRNA,0.78,1.81,-2.77,4.33,1.72,0.146,20.1,0.672,1,Wald,NF-kappaB Signaling,NM_016562.3:3098
SIRT5-mRNA,-0.0363,0.0844,-0.202,0.129,0.975,0.869,1.09,0.672,1,loglinear,Glucose Metabolism,NM_012241.3:300
PRKCZ-mRNA,-0.102,0.237,-0.566,0.363,0.932,0.675,1.29,0.672,1,lm.nb,"Insulin Signaling, Neurogenesis",NM_002744.4:943
CCNA1-mRNA,-0.61,1.42,-3.4,2.18,0.655,0.0949,4.52,0.673,1,Wald,Cell Cycle,NM_003914.3:1605
IL10RA-mRNA,0.745,1.82,-2.82,4.31,1.68,0.142,19.8,0.687,1,Wald,Cytokines,NM_001558.2:150
GRM7-mRNA,-0.549,1.35,-3.2,2.1,0.684,0.109,4.28,0.689,1,Wald,"Glutamatergic Synapse, Neuroactive Ligands and Receptors",NM_000844.2:2575
GRIN3A-mRNA,-0.215,0.531,-1.26,0.825,0.861,0.419,1.77,0.689,1,lm.nb,"Glutamatergic Synapse, Neuroactive Ligands and Receptors",NM_133445.2:3167
SPHK1-mRNA,-0.395,0.976,-2.31,1.52,0.76,0.202,2.86,0.69,1,Wald,"A2 Astrocyte, Calcium Signaling, Phagocytosis",NM_021972.2:895
MSR1-mRNA,0.538,1.34,-2.09,3.17,1.45,0.235,8.97,0.693,1,Wald,Microglia Neurodegenerative Phenotype (MGnD),NM_002445.3:326
ACAT1-mRNA,-0.0501,0.126,-0.298,0.198,0.966,0.813,1.15,0.696,1,lm.nb,Lipid Metabolism,NM_000019.3:282
GJB1-mRNA,0.545,1.38,-2.17,3.26,1.46,0.223,9.56,0.698,1,Wald,Gap Junctions,NM_000166.5:165
AMPH-mRNA,-0.134,0.344,-0.809,0.541,0.911,0.571,1.46,0.701,1,lm.nb,Phagocytosis,NM_001635.3:526
TRAC-mRNA,0.549,1.41,-2.22,3.32,1.46,0.214,9.99,0.702,1,Wald,T-cell signaling,ENST00000611116.1:361
CASP3-mRNA,-0.0371,0.0981,-0.229,0.155,0.975,0.853,1.11,0.709,1,lm.nb,Apoptosis,NM_004346.3:875
LILRB4-mRNA,0.78,2.06,-3.25,4.81,1.72,0.105,28.1,0.709,1,Wald,"Microglia Neurodegenerative Phenotype (MGnD), Stage 2 DAM",NM_001278429.3:543
ANK2-mRNA,-0.0561,0.151,-0.351,0.239,0.962,0.784,1.18,0.714,1,lm.nb,"Cytoskeletal Dynamics, Myelogenesis",NM_001148.5:11581
S100B-mRNA,-0.124,0.333,-0.776,0.528,0.918,0.584,1.44,0.714,1,lm.nb,"Astrocyte Markers, Myelogenesis, Neurogenesis",NM_006272.2:304
TRIM17-mRNA,0.805,2.18,-3.46,5.08,1.75,0.0906,33.7,0.716,1,Wald,Interferon Signaling,NM_001024940.2:755
CUX2-mRNA,-0.142,0.384,-0.894,0.611,0.906,0.538,1.53,0.716,1,lm.nb,"Neurogenesis, Neuronal Markers",NM_015267.3:303
PPP3CB-mRNA,-0.0862,0.24,-0.557,0.385,0.942,0.679,1.31,0.724,1,lm.nb,"Calcium Signaling, MAPK & PI3K",NM_021132.2:270
ZNF365-mRNA,-0.0961,0.27,-0.626,0.434,0.936,0.648,1.35,0.726,1,lm.nb,"Neurogenesis, Oligodendrocyte DifferentiationMaturation",NM_014951.2:493
MMUT-mRNA,-0.086,0.242,-0.561,0.389,0.942,0.678,1.31,0.726,1,lm.nb,Lipid Metabolism,NM_000255.2:2000
ITGA7-mRNA,0.0953,0.269,-0.433,0.623,1.07,0.741,1.54,0.727,1,lm.nb,Cell Migration,NM_002206.1:1170
OLFML3-mRNA,0.441,1.29,-2.08,2.96,1.36,0.237,7.79,0.735,1,Wald,"Microglial Markers, Primed Microglia",NM_020190.4:490
HSD11B1-mRNA,0.449,1.31,-2.13,3.02,1.37,0.229,8.13,0.736,1,Wald,,NM_181755.1:155
SGCE-mRNA,0.0476,0.142,-0.23,0.325,1.03,0.853,1.25,0.74,1,lm.nb,Cytoskeletal Dynamics,NM_001099400.1:1238
PTPRC-mRNA,0.594,1.77,-2.87,4.06,1.51,0.136,16.7,0.741,1,Wald,"Cell Migration, Phagocytosis, T-cell signaling",NM_080923.2:154
SIRPA-mRNA,-0.0493,0.147,-0.338,0.24,0.966,0.791,1.18,0.742,1,lm.nb,NO Metabolism and Signaling,NM_001040022.1:1573
TLR3-mRNA,0.291,0.871,-1.42,2,1.22,0.375,4,0.742,1,Wald,NF-kappaB Signaling,NM_003265.2:230
P2RY11-mRNA,0.458,1.38,-2.25,3.16,1.37,0.211,8.95,0.744,1,Wald,"Neuroactive Ligands and Receptors, Purinergic Signaling",NM_002566.4:729
PLLP-mRNA,-0.0955,0.297,-0.677,0.487,0.936,0.625,1.4,0.751,1,lm.nb,Myelogenesis,NM_015993.2:395
SYT13-mRNA,0.0828,0.261,-0.429,0.594,1.06,0.743,1.51,0.754,1,lm.nb,Cytoskeletal Dynamics,NM_001247987.2:848
MAD2L1-mRNA,-0.47,1.48,-3.38,2.44,0.722,0.0963,5.41,0.755,1,Wald,Cell Cycle,NM_002358.3:182
JAK2-mRNA,0.0663,0.209,-0.344,0.477,1.05,0.788,1.39,0.755,1,lm.nb,"JAK-STAT, NO Metabolism and Signaling",NM_004972.3:1464
IRF8-mRNA,0.579,1.85,-3.04,4.2,1.49,0.121,18.4,0.757,1,Wald,Interferon Signaling,NM_002163.2:253
KLRK1-mRNA,0.342,1.15,-1.9,2.59,1.27,0.267,6.02,0.769,1,Wald,,NM_007360.1:760
MAPK13-mRNA,0.501,1.69,-2.8,3.8,1.41,0.143,14,0.77,1,Wald,MAPK & PI3K,NM_002754.3:1050
ITGAM-mRNA,0.668,2.28,-3.8,5.14,1.59,0.0716,35.3,0.773,1,Wald,Cell Migration,NM_000632.3:515
SHANK2-mRNA,-0.0489,0.17,-0.382,0.284,0.967,0.768,1.22,0.776,1,lm.nb,"Cytoskeletal Dynamics, Glutamatergic Synapse, Neurogenesis",NM_012309.4:1992
CACNA1B-mRNA,-0.0591,0.207,-0.465,0.347,0.96,0.725,1.27,0.778,1,lm.nb,"Calcium Signaling, Dopaminergic Synapse, GABAergic Synapse, Ion Transport, MAPK & PI3K, Serotonergic Synapse",NM_000718.3:3664
ALDH1A1-mRNA,-0.427,1.5,-3.36,2.5,0.744,0.0975,5.68,0.778,1,Wald,Astrocyte Markers,NM_000689.3:11
FPR1-mRNA,0.401,1.41,-2.36,3.16,1.32,0.195,8.94,0.779,1,Wald,"Cytokines, Neuroactive Ligands and Receptors",NM_002029.3:350
CALM3-mRNA,-0.0772,0.273,-0.613,0.458,0.948,0.654,1.37,0.78,1,lm.nb,Calcium Signaling,NM_005184.4:405
ADGRL4-mRNA,-0.386,1.4,-3.13,2.36,0.765,0.114,5.12,0.786,1,Wald,Blood Brain Barrier,NM_022159.3:1980
CFI-mRNA,0.345,1.27,-2.14,2.83,1.27,0.227,7.1,0.789,1,Wald,Complement System,NM_000204.3:764
RASA1-mRNA,0.0384,0.149,-0.253,0.33,1.03,0.839,1.26,0.799,1,lm.nb,"Angiogenesis, MAPK & PI3K",NM_002890.2:980
GAL3ST1-mRNA,0.496,1.93,-3.28,4.27,1.41,0.103,19.4,0.8,1,Wald,Myelogenesis,NM_004861.1:1378
ALDH1L1-mRNA,-0.0783,0.306,-0.678,0.521,0.947,0.625,1.43,0.801,1,lm.nb,Astrocyte Markers,NM_012190.2:329
SLC25A4-mRNA,0.0542,0.212,-0.361,0.469,1.04,0.779,1.38,0.801,1,lm.nb,Calcium Signaling,NM_001151.4:375
KCNQ5-mRNA,0.0572,0.224,-0.382,0.496,1.04,0.767,1.41,0.801,1,lm.nb,"Cholinergic Synapse, Ion Transport",NM_001160132.1:1385
LPL-mRNA,-0.522,2.05,-4.55,3.5,0.696,0.0428,11.3,0.802,1,Wald,"Microglia Neurodegenerative Phenotype (MGnD), Stage 2 DAM",NM_000237.2:736
ABCG2-mRNA,0.0789,0.315,-0.538,0.696,1.06,0.689,1.62,0.805,1,lm.nb,Blood Brain Barrier,NM_004827.2:2025
CNTNAP1-mRNA,-0.0696,0.279,-0.617,0.478,0.953,0.652,1.39,0.806,1,lm.nb,"Cell Migration, Cytoskeletal Dynamics, Myelogenesis, Oligodendrocyte DifferentiationMaturation",NM_003632.2:4050
SYBU-mRNA,-0.0505,0.203,-0.448,0.347,0.966,0.733,1.27,0.806,1,lm.nb,Cytoskeletal Dynamics,NM_001099744.1:1492
KCND2-mRNA,0.0494,0.198,-0.34,0.438,1.03,0.79,1.36,0.806,1,lm.nb,"Ion Transport, Serotonergic Synapse",NM_012281.3:1645
CD4-mRNA,0.292,1.19,-2.03,2.62,1.22,0.244,6.14,0.808,1,Wald,T-cell signaling,NM_000616.4:975
CD9-mRNA,-0.0795,0.34,-0.746,0.587,0.946,0.596,1.5,0.818,1,lm.nb,"Myelogenesis, Neurogenesis, Oligodendrocyte DifferentiationMaturation, Primed Microglia, Stage 2 DAM",NM_001769.2:405
ATP6V1G2-mRNA,-0.0597,0.257,-0.563,0.443,0.959,0.677,1.36,0.818,1,lm.nb,"Ion Transport, Phagocytosis",NM_130463.4:277
ICAM2-mRNA,-0.0869,0.375,-0.822,0.648,0.942,0.566,1.57,0.819,1,lm.nb,Cell Migration,NM_000873.3:415
STMN4-mRNA,-0.0496,0.215,-0.47,0.371,0.966,0.722,1.29,0.82,1,lm.nb,"Cytoskeletal Dynamics, Neurogenesis, Oligodendrocyte Markers",NM_030795.2:362
CD14-mRNA,0.0957,0.417,-0.723,0.914,1.07,0.606,1.88,0.821,1,lm.nb,"A2 Astrocyte, NF-kappaB Signaling",NM_000591.2:885
TIE1-mRNA,0.397,1.73,-3,3.79,1.32,0.125,13.8,0.821,1,Wald,,NM_005424.2:2610
CNR1-mRNA,-0.0422,0.189,-0.412,0.328,0.971,0.751,1.26,0.825,1,lm.nb,"Cannabinoid Signaling, Neuroactive Ligands and Receptors",NM_001160226.1:1576
CLTA-mRNA,0.0259,0.118,-0.205,0.256,1.02,0.868,1.19,0.828,1,lm.nb,"Gap Junctions, Wnt Signaling",NM_001184762.1:421
AXL-mRNA,0.0533,0.242,-0.421,0.528,1.04,0.747,1.44,0.828,1,lm.nb,"Angiogenesis, Astrocyte Markers, Microglia Neurodegenerative Phenotype (MGnD), Neurogenesis, Primed Microglia, Stage 2 DAM",NM_021913.2:2190
ARNTL-mRNA,0.042,0.192,-0.334,0.418,1.03,0.793,1.34,0.829,1,lm.nb,"Circadian Signaling, Dopaminergic Synapse",NM_001030272.1:840
SLC2A5-mRNA,0.35,1.68,-2.94,3.64,1.27,0.13,12.5,0.837,1,Wald,"Glucose Metabolism, Microglial Markers, Primed Microglia",NM_003039.2:711
IL34-mRNA,-0.257,1.26,-2.72,2.21,0.837,0.151,4.62,0.84,1,Wald,Cytokines,NM_152456.1:860
NLRP1-mRNA,0.368,1.8,-3.17,3.9,1.29,0.111,15,0.841,1,Wald,Inflammasome,NM_033004.2:2135
HACD2-mRNA,-0.0298,0.146,-0.316,0.257,0.98,0.803,1.19,0.841,1,lm.nb,Lipid Metabolism,NM_198402.2:510
ATP2B4-mRNA,0.032,0.159,-0.28,0.344,1.02,0.823,1.27,0.843,1,lm.nb,"Calcium Signaling, Ion Transport, NO Metabolism and Signaling",NM_001684.4:2863
YWHAG-mRNA,-0.0492,0.252,-0.542,0.444,0.966,0.687,1.36,0.847,1,lm.nb,"Cell Cycle, Neurogenesis",NM_012479.4:389
ALAS1-mRNA,-0.0285,0.146,-0.315,0.258,0.98,0.804,1.2,0.848,1,lm.nb,Primed Microglia,NM_000688.4:395
DNM3-mRNA,0.0282,0.146,-0.258,0.314,1.02,0.836,1.24,0.849,1,lm.nb,"Antigen Processing and Presentation, Cytoskeletal Dynamics, Neurogenesis",NM_015569.3:750
NES-mRNA,0.065,0.339,-0.599,0.729,1.05,0.66,1.66,0.85,1,lm.nb,Cytoskeletal Dynamics,NM_006617.1:2345
SLPI-mRNA,0.152,0.8,-1.42,1.72,1.11,0.375,3.29,0.851,1,lm.nb,NF-kappaB Signaling,NM_003064.2:330
CCR5-mRNA,0.401,2.12,-3.75,4.55,1.32,0.0744,23.4,0.852,1,Wald,"Chemokines, Microglia Neurodegenerative Phenotype (MGnD), Primed Microglia",NM_000579.3:366
UNC79-mRNA,0.0315,0.168,-0.298,0.361,1.02,0.813,1.28,0.853,1,lm.nb,Ion Transport,NM_020818.5:1586
TNFRSF11A-mRNA,-0.237,1.28,-2.75,2.28,0.849,0.149,4.84,0.855,1,Wald,"Cytokines, NF-kappaB Signaling",NM_003839.3:226
SLCO2B1-mRNA,0.385,2.11,-3.76,4.53,1.31,0.0739,23.1,0.857,1,Wald,"Microglial Markers, Primed Microglia",NM_001145211.2:1974
SLC6A1-mRNA,-0.051,0.28,-0.601,0.499,0.965,0.66,1.41,0.857,1,lm.nb,"Astrocyte Markers, GABAergic Synapse",NM_003042.3:1315
NEFH-mRNA,0.122,0.673,-1.2,1.44,1.09,0.436,2.72,0.858,1,lm.nb,"Cytoskeletal Dynamics, Neurogenesis, Neuronal Markers",NM_021076.3:1350
SORL1-mRNA,-0.0256,0.142,-0.304,0.252,0.982,0.81,1.19,0.859,1,lm.nb,"Microglial Markers, Neurogenesis",NM_003105.4:2599
STAB1-mRNA,0.273,1.53,-2.73,3.27,1.21,0.151,9.67,0.86,1,Wald,Phagocytosis,NM_015136.2:95
CHRM2-mRNA,-0.17,0.96,-2.05,1.71,0.889,0.241,3.27,0.861,1,Wald,"Calcium Signaling, Cholinergic Synapse, Neuroactive Ligands and Receptors",NM_001006630.1:1170
CDK7-mRNA,-0.436,2.48,-5.29,4.42,0.739,0.0256,21.4,0.862,1,Wald,Cell Cycle,NM_001799.2:785
LYZ-mRNA,0.186,1.06,-1.89,2.27,1.14,0.269,4.81,0.862,1,Wald,"Microglia Neurodegenerative Phenotype (MGnD), Stage 1 DAM",NM_000239.2:305
BASP1-mRNA,0.0336,0.193,-0.345,0.412,1.02,0.788,1.33,0.863,1,lm.nb,Cytoskeletal Dynamics,NM_006317.4:675
GRK3-mRNA,0.0444,0.258,-0.46,0.549,1.03,0.727,1.46,0.865,1,lm.nb,Glutamatergic Synapse,NM_005160.2:1265
CLCF1-mRNA,-0.164,0.981,-2.09,1.76,0.893,0.235,3.39,0.869,1,Wald,"A2 Astrocyte, Cytokines, Neurogenesis",NM_013246.2:452
LSR-mRNA,0.283,1.77,-3.19,3.75,1.22,0.11,13.5,0.875,1,Wald,Blood Brain Barrier,NM_205835.3:1888
DLX1-mRNA,0.287,1.8,-3.24,3.82,1.22,0.106,14.1,0.875,1,Wald,"Neurogenesis, Oligodendrocyte DifferentiationMaturation, TGF-Beta Signaling",NM_001038493.2:240
HMOX1-mRNA,-0.0694,0.441,-0.933,0.794,0.953,0.524,1.73,0.876,1,lm.nb,Hypoxia,NM_002133.2:781
ADCY1-mRNA,-0.0427,0.273,-0.578,0.493,0.971,0.67,1.41,0.877,1,lm.nb,Calcium Signaling,NM_001281768.1:1006
SRGN-mRNA,0.0408,0.263,-0.474,0.556,1.03,0.72,1.47,0.878,1,lm.nb,A1 Astrocyte,NM_002727.3:462
ADRB1-mRNA,0.21,1.36,-2.45,2.87,1.16,0.182,7.33,0.879,1,Wald,"Calcium Signaling, Neuroactive Ligands and Receptors",NM_000684.1:795
MYCT1-mRNA,0.258,1.7,-3.07,3.58,1.2,0.119,12,0.881,1,Wald,,NM_025107.2:159
ULK1-mRNA,0.0237,0.156,-0.282,0.33,1.02,0.822,1.26,0.881,1,lm.nb,"Autophagy, Neurogenesis",NM_003565.1:465
SLC8A1-mRNA,-0.0434,0.287,-0.606,0.519,0.97,0.657,1.43,0.881,1,lm.nb,Calcium Signaling,NM_021097.1:440
CNTF-mRNA,0.6,3.98,-7.19,8.39,1.52,0.00684,336,0.882,1,Wald,"Astrocyte DifferentiationFunction, Cytokines, Cytoskeletal Dynamics, Neurogenesis",NM_000614.3:45
STAMBPL1-mRNA,0.0356,0.236,-0.427,0.498,1.02,0.744,1.41,0.882,1,lm.nb,Primed Microglia,NM_020799.2:1600
CD68-mRNA,0.239,1.61,-2.92,3.4,1.18,0.132,10.5,0.884,1,Wald,"Microglial Markers, Primed Microglia",NM_001251.2:1140
ADGRA2-mRNA,0.221,1.51,-2.74,3.18,1.17,0.15,9.07,0.885,1,Wald,Blood Brain Barrier,NM_032777.9:1278
MTOR-mRNA,0.0139,0.095,-0.172,0.2,1.01,0.887,1.15,0.885,1,lm.nb,"Autophagy, Insulin Signaling, Neurogenesis",NM_004958.3:1865
GLUL-mRNA,-0.0343,0.24,-0.505,0.436,0.977,0.705,1.35,0.888,1,lm.nb,"GABAergic Synapse, Glutamatergic Synapse, Microglia Neurodegenerative Phenotype (MGnD), Primed Microglia",NM_002065.6:1485
TBR1-mRNA,0.235,1.67,-3.03,3.5,1.18,0.122,11.3,0.889,1,Wald,Neurogenesis,NM_006593.4:345
NRG1-mRNA,-0.222,1.59,-3.33,2.89,0.857,0.0992,7.41,0.89,1,Wald,"Myelogenesis, Neurogenesis, Oligodendrocyte DifferentiationMaturation",NM_004495.2:995
UBE2G1-mRNA,0.0136,0.0999,-0.182,0.21,1.01,0.881,1.16,0.893,1,lm.nb,"Antigen Processing and Presentation, Proteotoxic Stress",NM_003342.4:653
THY1-mRNA,0.0355,0.265,-0.485,0.556,1.02,0.715,1.47,0.895,1,lm.nb,"Cytoskeletal Dynamics, Neurogenesis",NM_006288.4:1378
PLCB4-mRNA,-0.0221,0.17,-0.355,0.311,0.985,0.782,1.24,0.898,1,lm.nb,"Calcium Signaling, Wnt Signaling",NM_182797.2:994
MAP2-mRNA,0.0259,0.209,-0.384,0.436,1.02,0.766,1.35,0.902,1,lm.nb,"Cytoskeletal Dynamics, Neurogenesis, Neuronal Markers",NM_001039538.1:1156
PTGIS-mRNA,0.203,1.65,-3.03,3.43,1.15,0.123,10.8,0.903,1,Wald,"Lipid Metabolism, NO Metabolism and Signaling",NM_000961.3:1409
USP2-mRNA,-0.0266,0.219,-0.456,0.403,0.982,0.729,1.32,0.904,1,lm.nb,"Microglial Markers, Primed Microglia",NM_001243759.1:676
DLX2-mRNA,0.304,2.54,-4.68,5.29,1.23,0.0389,39.2,0.906,1,Wald,"Neurogenesis, Oligodendrocyte DifferentiationMaturation, TGF-Beta Signaling",NM_004405.3:590
DAGLA-mRNA,-0.027,0.23,-0.478,0.423,0.981,0.718,1.34,0.908,1,lm.nb,"Cannabinoid Signaling, Cytoskeletal Dynamics, Neurogenesis",NM_006133.2:150
P2RY13-mRNA,0.219,1.96,-3.63,4.07,1.16,0.0809,16.7,0.912,1,Wald,"Microglial Markers, Neuroactive Ligands and Receptors, Primed Microglia, Purinergic Signaling",NM_176894.2:211
THRB-mRNA,-0.0207,0.2,-0.412,0.371,0.986,0.751,1.29,0.918,1,lm.nb,Neuroactive Ligands and Receptors,NM_000461.4:385
CACNA2D1-mRNA,-0.0157,0.151,-0.312,0.281,0.989,0.806,1.21,0.919,1,lm.nb,"Calcium Signaling, Ion Transport",NM_000722.2:335
KCNK13-mRNA,0.197,1.91,-3.55,3.94,1.15,0.0856,15.3,0.919,1,Wald,Ion Transport,NM_022054.3:1184
SMAD3-mRNA,-0.0232,0.238,-0.49,0.443,0.984,0.712,1.36,0.923,1,lm.nb,"Microglia Neurodegenerative Phenotype (MGnD), Primed Microglia, TGF-Beta Signaling, Wnt Signaling",NM_005902.3:1490
E2F3-mRNA,-0.254,2.62,-5.39,4.88,0.838,0.0238,29.5,0.924,1,Wald,Cell Cycle,NM_001243076.2:290
CRKL-mRNA,-0.0108,0.115,-0.236,0.215,0.993,0.849,1.16,0.926,1,lm.nb,"Insulin Signaling, MAPK & PI3K, Neurotrophin Signaling, Phagocytosis",NM_005207.4:885
FLT1-mRNA,0.0282,0.302,-0.564,0.621,1.02,0.676,1.54,0.926,1,lm.nb,"Hypoxia, MAPK & PI3K",NM_002019.4:530
EGF-mRNA,0.264,2.85,-5.33,5.86,1.2,0.0249,58,0.927,1,Wald,"Cytokines, MAPK & PI3K",NM_001963.4:1022
KCND1-mRNA,0.234,2.56,-4.79,5.26,1.18,0.0362,38.3,0.928,1,Wald,Ion Transport,NM_004979.4:2400
B2M-mRNA,0.0282,0.312,-0.583,0.639,1.02,0.668,1.56,0.929,1,lm.nb,"Antigen Processing and Presentation, Primed Microglia, Stage 1 DAM",NM_004048.2:235
ADORA2B-mRNA,-0.186,2.1,-4.3,3.92,0.879,0.0509,15.2,0.93,1,Wald,"Calcium Signaling, Neuroactive Ligands and Receptors, Purinergic Signaling",NM_000676.2:1043
ATG12-mRNA,-0.012,0.138,-0.283,0.259,0.992,0.822,1.2,0.932,1,lm.nb,Autophagy,NM_004707.3:634
CROT-mRNA,-0.451,5.2,-10.6,9.74,0.732,0.000625,856,0.932,1,Wald,Lipid Metabolism,NM_021151.4:186
PHYH-mRNA,-0.256,2.99,-6.12,5.61,0.838,0.0144,48.7,0.933,1,Wald,Lipid Metabolism,NM_001037537.1:1015
ISLR2-mRNA,0.192,2.3,-4.32,4.7,1.14,0.0502,26,0.934,1,Wald,Neurogenesis,NM_001130136.1:820
NLRP3-mRNA,-0.205,2.5,-5.11,4.7,0.867,0.0289,26.1,0.936,1,Wald,Inflammasome,NM_001079821.2:415
P2RY14-mRNA,0.124,1.54,-2.9,3.15,1.09,0.134,8.85,0.937,1,Wald,"Neuroactive Ligands and Receptors, Purinergic Signaling",NM_014879.2:205
CAMK2D-mRNA,-0.0122,0.152,-0.311,0.287,0.992,0.806,1.22,0.937,1,lm.nb,Calcium Signaling,NM_172127.1:505
TRIM45-mRNA,-0.188,2.35,-4.79,4.42,0.878,0.036,21.4,0.937,1,Wald,Interferon Signaling,NM_025188.4:1500
VIM-mRNA,0.0321,0.423,-0.797,0.861,1.02,0.576,1.82,0.94,1,lm.nb,"Astrocyte DifferentiationFunction, Astrocyte Markers, Cytoskeletal Dynamics",NM_003380.2:694
APOE-mRNA,-0.0231,0.307,-0.624,0.578,0.984,0.649,1.49,0.941,1,lm.nb,"Astrocyte Markers, Microglia Neurodegenerative Phenotype (MGnD), Primed Microglia, Stage 1 DAM",NM_000041.2:96
CACNA1E-mRNA,0.133,2.05,-3.89,4.15,1.1,0.0676,17.8,0.949,1,Wald,"Calcium Signaling, Ion Transport, MAPK & PI3K",NM_000721.3:4830
RASGRP1-mRNA,-0.032,0.501,-1.01,0.95,0.978,0.495,1.93,0.95,1,lm.nb,"MAPK & PI3K, T-cell signaling",NM_005739.3:365
HSPA1A-mRNA,-0.0412,0.645,-1.31,1.22,0.972,0.404,2.34,0.95,1,lm.nb,"Microglial Markers, Proteotoxic Stress",NM_005345.5:1875
GRIA2-mRNA,0.012,0.193,-0.366,0.39,1.01,0.776,1.31,0.951,1,lm.nb,"Cannabinoid Signaling, Dopaminergic Synapse, Glutamatergic Synapse, Neuroactive Ligands and Receptors",NM_001083620.1:865
CKB-mRNA,0.00987,0.163,-0.309,0.329,1.01,0.807,1.26,0.952,1,lm.nb,"Astrocyte Markers, Primed Microglia",NM_001823.4:320
GZMB-mRNA,0.0859,1.44,-2.73,2.91,1.06,0.15,7.49,0.953,1,Wald,Apoptosis,NM_004131.3:540
RNASEL-mRNA,0.131,2.29,-4.35,4.61,1.09,0.049,24.5,0.955,1,Wald,Interferon Signaling,NM_021133.3:1094
PDHA1-mRNA,0.00509,0.0924,-0.176,0.186,1,0.885,1.14,0.957,1,lm.nb,Glucose Metabolism,NM_000284.3:1080
NGF-mRNA,0.0731,1.34,-2.55,2.69,1.05,0.171,6.46,0.957,1,Wald,"Cytokines, Cytoskeletal Dynamics, Neurogenesis, Neurotrophin Signaling",NM_002506.2:634
TRIM46-mRNA,0.0725,1.33,-2.54,2.69,1.05,0.172,6.43,0.957,1,Wald,"Cytoskeletal Dynamics, Interferon Signaling, Neurogenesis",NM_025058.4:848
B3GNT5-mRNA,0.0812,1.54,-2.93,3.1,1.06,0.131,8.56,0.958,1,Wald,A2 Astrocyte,NM_032047.4:688
NOSTRIN-mRNA,0.0769,1.5,-2.85,3.01,1.05,0.138,8.04,0.96,1,Wald,,NM_001039724.3:1125
SELENOS-mRNA,0.128,2.53,-4.83,5.09,1.09,0.0351,34,0.96,1,Wald,"NO Metabolism and Signaling, Proteotoxic Stress",NM_203472.1:466
RXFP1-mRNA,-0.0447,0.937,-1.88,1.79,0.969,0.272,3.46,0.962,1,Wald,Neuroactive Ligands and Receptors,NM_021634.4:719
CD40-mRNA,-0.0977,2.07,-4.15,3.96,0.935,0.0563,15.5,0.963,1,Wald,"Microglial Markers, NF-kappaB Signaling",NM_001250.4:196
FBLN5-mRNA,0.0792,1.77,-3.38,3.54,1.06,0.0957,11.7,0.965,1,Wald,A1 Astrocyte,NM_006329.3:1728
NCAN-mRNA,0.011,0.246,-0.471,0.493,1.01,0.721,1.41,0.965,1,lm.nb,Astrocyte Markers,NM_004386.3:3120
DOCK3-mRNA,0.012,0.272,-0.52,0.544,1.01,0.697,1.46,0.965,1,lm.nb,Neurotrophin Signaling,NM_004947.4:3020
MKRN1-mRNA,-0.00442,0.103,-0.206,0.197,0.997,0.867,1.15,0.966,1,lm.nb,Antigen Processing and Presentation,NM_013446.4:935
MEF2A-mRNA,0.0047,0.115,-0.221,0.231,1,0.858,1.17,0.968,1,lm.nb,"Cytokines, Microglia Neurodegenerative Phenotype (MGnD), Neurogenesis, Neurotrophin Signaling",NM_005587.2:840
ABCC8-mRNA,0.0686,1.77,-3.4,3.54,1.05,0.0945,11.6,0.97,1,Wald,Ion Transport,NM_000352.4:1760
RFX4-mRNA,-0.0121,0.316,-0.632,0.608,0.992,0.645,1.52,0.97,1,lm.nb,Astrocyte Markers,NM_213594.1:630
NOS2-mRNA,-0.0384,1.07,-2.13,2.05,0.974,0.229,4.15,0.972,1,Wald,"Hypoxia, Microglia Neurodegenerative Phenotype (MGnD), NO Metabolism and Signaling, Oxidative & Nitrosative Stress",NM_000625.4:605
FCAR-mRNA,0.045,1.28,-2.47,2.56,1.03,0.18,5.9,0.972,1,Wald,,NM_133278.2:750
YWHAQ-mRNA,-0.00266,0.0791,-0.158,0.152,0.998,0.896,1.11,0.974,1,lm.nb,Cell Cycle,NM_006826.3:558
SQSTM1-mRNA,0.00461,0.146,-0.281,0.29,1,0.823,1.22,0.975,1,lm.nb,Autophagy,NM_001142298.1:489
ATP2B3-mRNA,-0.0127,0.415,-0.826,0.8,0.991,0.564,1.74,0.976,1,lm.nb,"Calcium Signaling, Ion Transport",NM_001001344.2:1280
PIK3CB-mRNA,0.00537,0.194,-0.374,0.385,1,0.772,1.31,0.978,1,lm.nb,MAPK & PI3K,NM_006219.1:2945
UBQLN2-mRNA,0.0035,0.126,-0.244,0.251,1,0.844,1.19,0.978,1,lm.nb,Proteotoxic Stress,NM_013444.3:1080
HEXB-mRNA,0.00399,0.145,-0.28,0.288,1,0.824,1.22,0.978,1,lm.nb,"Homeostatic Microglia, Microglial Markers, Neurogenesis",NM_000521.3:950
SLC11A1-mRNA,-0.0201,0.801,-1.59,1.55,0.986,0.332,2.93,0.98,1,Wald,"Microglial Markers, Phagocytosis",NM_000578.3:1679
GRM2-mRNA,-0.0397,1.7,-3.38,3.3,0.973,0.0964,9.82,0.982,1,Wald,"Glutamatergic Synapse, Neuroactive Ligands and Receptors",NM_001349116.2:395
CCNH-mRNA,0.00218,0.098,-0.19,0.194,1,0.877,1.14,0.982,1,lm.nb,Cell Cycle,NM_001199189.1:1152
TPSAB1/B2-mRNA,-0.0224,1.33,-2.62,2.58,0.985,0.163,5.96,0.987,1,Wald,,NM_003294.3:579
CTTNBP2NL-mRNA,-0.00174,0.14,-0.276,0.272,0.999,0.826,1.21,0.99,1,lm.nb,Microglial Markers,NM_018704.2:1074
SLC10A6-mRNA,0.0155,1.29,-2.5,2.54,1.01,0.176,5.8,0.991,1,Wald,A2 Astrocyte,NM_197965.2:646
GALC-mRNA,-0.0582,5.25,-10.3,10.2,0.96,0.000767,1200,0.991,1,Wald,"Myelogenesis, Primed Microglia",NM_000153.2:725
EMCN-mRNA,0.0054,1.79,-3.5,3.51,1,0.0887,11.4,0.998,1,Wald,,NM_016242.3:160
